1
|
Zapletal J, Nanka O, Halaska MJ, Maxova K, Hajkova Hympanova L, Krofta L, Rob L. Anatomy of the pudendal nerve in clinically important areas: a pictorial essay and narrative review. Surg Radiol Anat 2024; 46:211-222. [PMID: 38240796 DOI: 10.1007/s00276-023-03285-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2023] [Accepted: 12/14/2023] [Indexed: 02/15/2024]
Abstract
PURPOSE The pudendal nerve is an anatomical structure arising from the ventral branches of the spinal roots S2-S4. Its complex course may be affected by surrounding structures. This may result in irritation or entrapment of the nerve with subsequent clinical symptoms. Aim of this study is to review the anatomy of the pudendal nerve and to provide detailed photographic documentation of the areas with most frequent clinical impact which are essential for surgical approach. METHODS Major medical databases were searched to identify all anatomical studies investigating pudendal nerve and its variability, and possible clinical outcome of these variants. Extracted data consisted of morphometric parameters, arrangement of the pudendal nerve at the level of roots, formation of pudendal nerve, position according to sacrospinal and sacrotuberal ligaments and its terminal branches. One female cadaver hemipelvis was dissected with common variability of separate course of inferior rectal nerve. During dissection photodocumentation was made to record course of pudendal nerve with focus on areas with recorded pathologies and areas exposed to iatrogenic damage during surgical procedures. RESULTS Narrative review was done to provide background for photodocumentation. Unique photos of course of the pudendal nerve was made in areas with great clinical significance. CONCLUSION Knowledge of anatomical variations and course of the pudendal nerve is important for examinations and surgical interventions. Surgically exposed areas may become a site for iatrogenic damage of pudendal nerve; therefore, unique picture was made to clarify topographic relations.
Collapse
Affiliation(s)
- Jan Zapletal
- Department of Obstetrics and Gynaecology, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Srobarova 1150/50, 100 34, Prague 10, Czech Republic.
| | - O Nanka
- Institute of Anatomy, First Faculty of Medicine, Charles University, U Nemocnice 3, 128 00, Prague 2, Czech Republic
| | - M J Halaska
- Department of Obstetrics and Gynaecology, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Srobarova 1150/50, 100 34, Prague 10, Czech Republic
| | - K Maxova
- Department of Obstetrics and Gynaecology, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Srobarova 1150/50, 100 34, Prague 10, Czech Republic
| | - L Hajkova Hympanova
- Institute for the Care of Mother and Child Prague, Third Faculty of Medicine, Charles University, Podolske nabrezi 157, 147 00, Prague, Czech Republic
| | - L Krofta
- Institute for the Care of Mother and Child Prague, Third Faculty of Medicine, Charles University, Podolske nabrezi 157, 147 00, Prague, Czech Republic
| | - L Rob
- Department of Obstetrics and Gynaecology, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Srobarova 1150/50, 100 34, Prague 10, Czech Republic
| |
Collapse
|
2
|
Hruda M, Sehnal B, Halaška MJ, Drozenová J, Robová H, Pichlík T, Rob L. New staging of endometrial carcinoma - FIGO 2023. Ceska Gynekol 2024; 89:120-127. [PMID: 38704224 DOI: 10.48095/cccg2024120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/06/2024]
Abstract
AIM To review the changes in the new version of the FIGO 2023 staging system for endometrial cancer. METHODS AND RESULTS The new FIGO 2023 endometrial cancer staging system provides key updates for the diagnosis and treatment of endometrial cancer. An important step in diagnosis is molecular classification, which allows more accurate risk stratification for recurrence and the identification of targeted therapies. The new staging system, based on the recommendations of the international societies ESGO, ESTRO and ESP, incorporates not only the description of the pathological and anatomical extent of the disease, but also the histopathological characteristics of the tumour, including the histological type and the presence of lymphovascular space invasion. In addition, the staging system uses molecular testing to classify endometrial cancers into four prognostic groups: POLEmut, MMRd, NSMP and p53abn. Each group has its own specific characteristics and prognosis. The most significant changes have occurred in stages I and II, in which the sub-staging better reflects the biological behaviour of the tumour. This update increases the accuracy of prognosis and improves individualized treatment options for patients with endometrial cancer. CONCLUSION The updated FIGO staging of endometrial cancer for 2023 incorporates different histologic types, tumour features, and molecular classifications to better reflect the current improved understanding of the complex nature of several endometrial cancer types and their underlying bio logic behaviour. The aim of the new endometrial cancer staging system is to better define stages with similar prognosis, allowing for more precise indication of individualised adjuvant radiation or systemic treatment, including the use of immunotherapy.
Collapse
|
3
|
Brych O, Drozenová J, Pichlík T, Hruda M, Rob L, Robová H, Waldauf P, Themistocleous P, Halaška MJ. Preoperative and postoperative staging in endometrial cancer - a prospective study. Ceska Gynekol 2024; 89:5-10. [PMID: 38418246 DOI: 10.48095/cccg20245] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/01/2024]
Abstract
OBJECTIVE The aim of this study was to determine how often changes the stage of the tumour in definitive histology against preoperative clinical stage in patient cohort with diagnosed endometrial cancer. METHODS We evaluated prospectively a cohort of 166 patients with endometrial cancer. They all underwent abdominal hysterectomy, bilateral salpingo-oophorectomy, sentinel lymph node biopsy. Patients with high-risk tumours also pelvic lymfadenectomy. We collected data of preoperative diagnostic biopsy and postoperative definitive histology. The data were statistically processed. RESULTS Detection of sentinel lymph node was successful in 71.1%, bilateral successful detection was in 40.6%. Discrepancy of tumour grade between preoperative biopsy and definitive histology was generally 31.4%. Upgrading of the tumour was in 22 (14.4%) cases, downgrading in 26 (17%) cases. Upgrade from low-risk to high-risk group of tumours was noticed in eight cases. Histopathological tumour type changed in 6.6%, 4.6% moved to histopathologic high-risk group. The tumour stage changed in definite histology in 57.3%, in 19.2% of cases moved from stage low/intermediate-risk group to intermediate-high/high-risk disease group. CONCLUSION Correct assessment of preoperative clinical stage and histological grade of endometrial cancer is burdened with a high inaccuracy rate. A lot of cases is up-staged after surgical staging and moved to intermediate-high/high-risk disease group. Results confirm the importance of oncogynaecologic centre II. evaluation of histopathology findings from diagnostic biopsies made in referring hospitals. Sentinel lymph node biopsy should be performed even in clinically low/intermediate-risk disease group.
Collapse
|
4
|
Sehnal B, Halaška MJ, Vlk R, Drochýtek V, Pichlík T, Hruda M, Robová H, Rob L, Tachezy R. Human papillomavirus infection (HPV) and pregnancy. Epidemiol Mikrobiol Imunol 2024; 73:37-50. [PMID: 38697839 DOI: 10.61568/emi/11-6254/20240123/136241] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/05/2024]
Abstract
Human papillomavirus (HPV) is the most common sexually transmitted viral infection worldwide, which may result in the development in benign lesions or malignant tumors. The prevalence of HPV infection is twice as high in pregnancy as in non-pregnant women. Additionally, there is a risk of vertical transmission of HPV from mother to fetus during pregnancy or childbirth. Various studies have reported an increased risk of adverse pregnancy outcomes in HPV-positive women, including miscarriage, preterm birth, premature rupture of membranes, preeclampsia, fetal growth restriction, and fetal death. HPV vaccination is not currently recommended during pregnancy. On the other hand, there is no evidence linking HPV vaccination during pregnancy with adverse pregnancy outcomes and termination of pregnancy is not justified in this case.
Collapse
|
5
|
Sládečková M, Bendová M, Kubecová M, Hruda M, Rob L, Halaška MJ. Management of patient with breast carcinoma diagnosed during pregnancy. Ceska Gynekol 2019; 84:293-297. [PMID: 31818113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
OBJECTIVE To present actual complex review of diagnosis and treatment of breast cancer during pregnancy, demonstrated on particular case report. DESIGN Case report and review article. SETTING University Hospital Královské Vinohrady, Prague Department of Obstetrics and Gynaecology, Department of Radiotherapy and Oncology. CASE REPORT Patient with breast cancer diagnosed in early pregnancy, her oncological treatment. Circumstantial finding was endometriosis of rectovaginal septum and dehiscence of uterotomy after C-section. DISCUSSION On this case we demonstrate importance of all early diagnosis, prompt examination management and early therapy onset already during the pregnancy. CONCLUSION Breast cancer therapy results are equal in pregnant and non-pregnant women, when we compare patients of same age, with same stage and same biological characteristics of tumor. The obstacle during pregnancy is often late diagnosis, which causes bigger size of tumor and more extensive affection of lymphatics in time of therapy onset.
Collapse
|
6
|
Pichlík T, Rob L, Robová H, Halaška MJ, Drozenová J, Hruda M, Drochýtek V. Individualization of surgical management of cervical cancer stages IA1, IA2. Ceska Gynekol 2019; 84:172-176. [PMID: 31324105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
OBJECTIVE To evaluate the risk of involvement of sentinel lymph nodes in cervical cancer stage IA1 with lymphovascular space invasion and IA2 using the detection of sentinel lymph nodes. DESIGN Original article. SETTINGS Department of Gynecology and Obstetrics 3rd Faculty of Medicine, Charles University, Faculty Hospital Královské Vinohrady, Prague; Oncogynecological centrum; Department of Pathology 3rd Faculty of Medicine, Charles University, Faculty Hospital Kralovské Vinohrady, Prague. METHODS The study included women from prospective protocols LAP I and LAP II with cervical cancer stage IA1 with lymphovascular space invasion and stage IA2 from 2002 to 2018 classified according to FIGO 2014 staging, TNM 8. Detection of sentinel lymph nodes throughout this period was performed using ultra-short protocol with Tc and patent blau and also by histopathological examination. RESULTS In the first group (28 women) with stage IA1 and lymphovascular space invasion diagnosed from cone biopsy there were two women with positive lymph nodes (7.1%). In the group stage IA2 (34 women) there were 13 women (38.2%) with positive lymphovascular space invasion and two women had positive lymph nodes (5.9%). The risk of positive lymph nodes for stage IA1 with lymphovascular space invasion and for stage IA2 is not statistically significant OR = 0.8125 (95% CI 0.1070-6.172). CONCLUSION The detection of sentinel lymph nodes aids to individualize the therapy of early stage cervical cancer and helps to reduce the radicalization of surgery. The risk of positive lymph nodes in stage IA1 with lymphovascular space invasion and stage IA2 with/without lymphovascular space invasion is the same. The results confirm, that the detection of sentinel lymph nodes in stage IA1 with lymphovascular space invasion is fully indicated.
Collapse
|
7
|
Řeháčková M, Maxová K, Bárta J, Halaška MJ, Rob L. Bladder rupture after a fall on the ground in a patient with total uterine prolapse. Ceska Gynekol 2019; 84:289-292. [PMID: 31818112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
OBJECTIVE The aim of this work is to present a case of traumatic bladder rupture in a patient with total uterine prolapse. Additionally, we provide a brief description of this issue. DESIGN Case report. SETTING Department of Obstetrics and Gynaecology, 3rd Faculty of Medicine, Charles University and Královské Vinohrady University Hospital, Prague; Departement of Radiology, 3rd Faculty of Medicine, Charles University and Královské Vinohrady University Hospital, Prague. RESULTS We present a case report of a patient with a total uterine prolapse that has been examined for a lower abdominal pain, hematuria and difficulties with urination. The problems arose suddenly after the fall on the ground. These symptoms are typical for bladder rupture, but other more frequent causes have to be ruled out. CT scan showed a contrast agent leak from the bladder. The patient was indicated for surgical revision and suture of the bladder wall. CONCLUSION Separately, rupture of the bladder occurs rarely. Most often, this injury is part of a wider trauma - especially after car crashes. However, our case report suggests that this option should be considered.
Collapse
|
8
|
Heřman J, Rob L, Robová H, Drochýtek V, Hruda M, Pichlík T, Kujal P, Drozenová J. Histopathological and clinical features of molar pregnancy. Ceska Gynekol 2019; 84:418-424. [PMID: 31948249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
OBJECTIVE To analyse own set of molar pregnancies and to develop clinically relevant procedures. TYPE OF STUDY Review article with analysis of own data. SETTINGS Department of Pathology 3rd Faculty of Medicine, Charles University, Faculty Hospital Královské Vinohrady, Prague; Department of Obstetrics and Gynecology 3rd Faculty of Medicine, Charles University, Faculty Hospital Královské Vinohrady, Prague. INTRODUCTION The study monitors the decrease of laboratory values of beta-subunit of hCG gonadotropin (beta-hCG) after evacuation of partial and complete hydatidiform moles in a set of 45 partial and 46 complete moles. Two case reports of invasive moles. RESULTS In cases of partial hydatidiform moles there was complete regression of beta-hCG in all cases, 89% regressed in six weeks, none of the women showed no subsequent elevation after reaching negativity. In cases of complete hydatidiform moles the decrease was less gradual, the negativity after six weeks was confirmed in 78%, three complete moles became malignant. CONCLUSION The decrease of beta-hCG after molar pregnancy termination is variable. Even if in cases of complete hydatidiform moles the risk of malignization after reaching negativity is low, beta-hCG checks are recommended at monthly intervals for 6 months. Correct diagnosis of complete mole and its differentiation from partial mole can be achieved using immunohistochemistry - p57 antibody.
Collapse
|
9
|
Aparicio T, Ducreux M, Faroux R, Barbier E, Manfredi S, Lecomte T, Etienne PL, Bedenne L, Bennouna J, Phelip JM, François E, Michel P, Legoux JL, Gasmi M, Breysacher G, Rougier P, De Gramont A, Lepage C, Bouché O, Seitz JF, Adenis A, Alessio A, Aouakli A, Azzedine A, Bedjaoui A, Bidault A, Blanchi A, Botton A, Cadier-Lagnes A, Fatisse A, Gagnaire A, Gilbert A, Gueye A, Hollebecque A, Lemaire A, Mahamat A, Marre A, Patenotte A, Rotenberg A, Roussel A, Thirot-Bidault A, Votte A, Weber A, Zaanan A, Dupont-Gossart A, Villing A, Queuniet A, Coudert B, Denis B, Garcia B, Lafforgue B, Landi B, Leduc B, Linot B, Paillot B, Rhein B, Winkfield B, Barberis C, Becht C, Belletier C, Berger C, Bineau C, Borel C, Brezault C, Buffet C, Cornila C, Couffon C, De La Fouchardière C, Giraud C, Lecaille C, Lepere C, Lobry C, Locher C, Lombard-Bohas C, Paoletti C, Platini C, Rebischung C, Sarda C, Vilain C, Briac-Levaché C, Auby D, Baudet-Klepping D, Bechade D, Besson D, Cleau D, Festin D, Gargot D, Genet D, Goldfain D, Luet D, Malka D, Peré-Vergé D, Pillon D, Sevin-Robiche D, Smith D, Soubrane D, Tougeron D, Zylberait D, Carola E, Cuillerier E, Dorval Danquechin E, Echinard E, Janssen E, Maillard E, Mitry E, Norguet-Monnereau E, Suc E, Terrebonne E, Zrihen E, Pariente E, Almaric F, Audemar F, Bonnetain F, Desseigne F, Dewaele F, Di Fiore F, Ghiringhelli F, Husseini F, Khemissa F, Kikolski F, Morvan F, Petit-Laurent F, Riot F, Subtil F, Zerouala-Boussaha F, Caroli-Bosc F, Boilleau-Jolimoy G, Bordes G, Cavaglione G, Coulanjon G, Deplanque G, Gatineau-Saillant G, Goujon G, Medinger G, Roquin G, Brixi-Benmansour H, Castanie H, Lacroix H, Maechel H, Perrier H, Salloum H, Senellart H, Baumgaertner I, Cumin I, Graber I, Trouilloud I, Boutin J, Butel J, Charneau J, Cretin J, Dauba J, Deguiral J, Egreteau J, Ezenfis J, Forestier J, Goineau J, Lacourt J, Lafon J, Martin J, Meunier J, Moreau J, Provencal J, Taieb J, Thaury J, Tuaillon J, Vergniol J, Villand J, Vincent J, Volet J, Bachet J, Barbare J, Souquet J, Grangé J, Dor J, Paitel J, Jouve J, Raoul J, Cheula J, Gornet J, Sabate J, Vantelon J, Vaillant J, Aucouturier J, Barbieux J, Herr J, Lafargue J, Lagasse J, Latrive J, Plachot J, Ramain J, Robin J, Spano J, Douillard J, Beerblock K, Bouhier-Leporrier K, Slimane Fawzi K, Cany L, Chone L, Dahan L, Gasnault L, Rob L, Stefani L, Wander L, Baconnier M, Ben Abdelghani M, Benchalal M, Blasquez M, Carreiro M, Charbit M, Combe M, Duluc M, Fayolle M, Gignoux M, Giovannini M, Glikmanas M, Mabro M, Mignot M, Mornet M, Mousseau M, Mozer M, Pauwels M, Pelletier M, Porneuf M, Ramdani M, Schnee M, Tissot M, Zawadi M, Clavero-Fabri M, Gouttebel M, Kaminsky M, Galais M, Abdelli N, Barrière N, Bouaria N, Bouarioua N, Delas N, Gérardin N, Hess-Laurens N, Stremsdoerfer N, Berthelet O, Boulat O, Capitain O, Favre O, Amoyal P, Bergerault P, Burtin P, Cassan P, Chatrenet P, Chiappa P, Claudé P, Couzigou P, Feydy P, Follana P, Geoffroy P, Godeau P, Hammel P, Laplaige P, Lehair P, Martin P, Novello P, Pantioni P, Pienkowski P, Pouderoux P, Prost P, Ruszniewski P, Souillac P, Texereau P, Thévenet P, Haineaux P, Benoit R, Coriat R, Lamy R, Mackiewicz R, Beorchia S, Chaussade S, Hiret S, Jacquot S, Lavau Denes S, Montembault S, Nahon S, Nasca S, Nguyen S, Oddou-Lagraniere S, Pesque-Penaud S, Fratte S, Chatellier T, Mansourbakht T, Morin T, Walter T, Boige V, Bourgeois V, Derias V, Guérin-Meyer V, Hautefeuille V, Jestin Le Tallec V, Lorgis V, Quentin V, Sebbagh V, Veuillez V, Adhoute X, Coulaud X, Becouarn Y, Coscas Y, Courouble Y, Le Bricquir Y, Molin Y, Rinaldi Y, Lam Y, Ladhib Z. Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials. Eur J Cancer 2018; 98:1-9. [DOI: 10.1016/j.ejca.2018.03.031] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2018] [Revised: 03/26/2018] [Accepted: 03/28/2018] [Indexed: 02/07/2023]
|
10
|
Velíšková M, Vlk R, Halaška MJ, Minajev G, Krejčí T, Rob L. [Rupture of focal nodular hyperplasia in the 37th week of pregnanacy - case report]. Ceska Gynekol 2016; 81:218-221. [PMID: 27882766] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
OBJECTIVE We describe a case of spontaneous hepatic rupture associated with undiagnosed focal nodular hyperplasia of a patient in the third trimester of pregnancy. Additionally, we provide a brief review of literature. DESIGN Case report. SETTING Department of Obstetrics and Gynaecology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague. RESULTS We report the case of a 29 year old patient with otherwise physiological pregnancy, who was hospitalized with pain in left hypochondrium. The patient experienced painful respiration, increasing in intensity in supine position. The possibility of lung embolism was considered and ruled out. Based on a suspected haemoperitoneum, caesarean section was performed. During the inspection of peritoneal cavity a ruptured tumor on the liver was identified. Histological examination showed focal nodular hyperplasia. CONCLUSION Focal nodular hyperplasia is a benign liver lesion. Complications involving rupture or bleeding are very rare. 17 cases of hepatic rupture associated with focal nodular hyperplasia were described in published reports with only one case related to pregnancy. Our case emphasizes the importance of a close cooperation between a gynaecologist, radiologist and surgeon.
Collapse
|
11
|
Silvester W, Detering K, Fraser SA, Sellars M, Rob L. O-50 Conversing across the cultural divide – advance care planning (ACP) with culturally and linguistically diverse (CALD) patients. BMJ Support Palliat Care 2015. [DOI: 10.1136/bmjspcare-2015-000978.49] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
12
|
Železná Teyschlová M, Rob L, Robová H, Pluta M, Machač J. [Ovaria borderline tumor - fertility-sparing surgery; case report]. Ceska Gynekol 2015; 80:162-166. [PMID: 25944608] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
The borderline tumors are known as low malignant potential tumors. Usually younger women suffer for them, than by the invasive ovarian carcinoma. They often which to be pregnant. The fertility-sparing surgery is posile but contain higher risk of the new disease on contralateral ovary.
Collapse
|
13
|
Abstract
Cervical cancer is one of the most common cancers in women worldwide. Because it often affects women of childbearing age (19–45 years), fertility-sparing surgery is an important issue. The article reviews current viable fertility-sparing options with a special focus on trachelectomy, including vaginal radical trachelectomy, abdominal radical trachelectomy and simple trachelectomy. Neoadjuvant chemotherapy is also discussed. Finally, the decision to proceed with fertility-sparing treatment should be a patient-driven process.
Collapse
Affiliation(s)
- Mj Halaska
- Department of Obstetrics and Gynaecology, Second Medical Faculty, Charles University, Prague 150 00, Czech Republic
| | - H Robova
- Department of Obstetrics and Gynaecology, Second Medical Faculty, Charles University, Prague 150 00, Czech Republic
| | - M Pluta
- Department of Obstetrics and Gynaecology, Second Medical Faculty, Charles University, Prague 150 00, Czech Republic
| | - L Rob
- Department of Obstetrics and Gynaecology, Second Medical Faculty, Charles University, Prague 150 00, Czech Republic
| |
Collapse
|
14
|
Amant F, Uzan C, Han S, Fruscio R, Steffensen KD, Škultéty J, Giuliani D, Mephon A, Rouzier R, Witteveen P, Locatelli A, Rob L, Halaska M. Matched Cohort Study on Patients with Cervical Cancer Diagnosed During Pregnancy. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu338.49] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
15
|
Rob L, Robova H, Pluta M, Halaska M, Matecha J, Skapa P. Less radical surgery than radical trachelectomy or radical hysterectomy in patients with stage I cervical cancer. Gynecol Oncol 2014. [DOI: 10.1016/j.ygyno.2014.03.181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
16
|
Robova H, Rob L, Pluta M, Halaska M, Matecha J, Skapa P. Fertility-sparing surgery after high dose-dense neoadjuvant chemotherapy: Critical view of experiences with 25 patients. Gynecol Oncol 2014. [DOI: 10.1016/j.ygyno.2014.03.179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Marinescu G, Popa S, Panzaru C, Rob L. EPA-1609 - Olanzapine, a good choice for tactile hallucinations of blind schizophrenic patients. Eur Psychiatry 2014. [DOI: 10.1016/s0924-9338(14)78760-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
18
|
Ventruba P, Feyereisl J, Janda P, Kučera E, Martan A, Novotný Z, Pilka R, Rob L, Rokyta Z, Spaček J, Tošner J. [Doctors specialty training in obstetrics and gynecology at university medical schools: 2012-2013]. Ceska Gynekol 2013; 78:486-490. [PMID: 24313437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
OBJECTIVE The paper addresses transfer of doctors specialty training from the national Institute of postgraduate medical education (IPVZ) to University Medical Schools (UMS) with the special focus to Obstetrics and Gynecology (OG). METHODS The National Specialty Board (NSB) has been established. NSB tasks include definition of inclusion criteria and process of specialty choice at UMS. In OG specialty there are defined mid-term and final postgraduate training courses and other requirements for final specialty exam (FSE) - in particular trainees scientific work and surgery done with the supervision of NTB member. The system of FSE, its content, application, reimbursement and mechanisms are described in details. RESULTS In the whole country in 2012 there have been done 864 FSE in all basic medical specialties, which took place at seven UMS. Autumn semester terms has been utilized significantly more than spring terms (57% vs. 43%). There have been differences in the numbers of specialties and also numbers of candidates in each specialty among different UMS. In total 94% of applicants succeed in the FSE. In 2012 within OG specialty training there has been held 56 FSE - 24 exams on five UMS in spring term and 32 (57%) exams only on two UMS in autumn term. In the spring 2013 FSE were organized on 1st LF UK in Prague with 23 applicants, from which 22 successfully passed. During autumn 2013 the FSE in OG will be held on LF UP in Olomouc with 44 applicants for final postgraduate training course and 39 candidates for FSE. CONCLUSION Within OG specialty the transfer of doctors specialty training from IPVZ to UMS has been successfully managed. The NSB in OG specialty closely cooperates with past IPVZ and the Accreditation Commission of the Czech Ministry of Health. Thus continuity, quality and continuous enhancement of specialty training program in OG in Czech Republic is assured.
Collapse
|
19
|
Nováčková M, Halaška MJ, Malá I, Robová H, Pluta M, Chmel R, Rob L. [Lymphedema after vulvar cancer surgery. A prospective study]. Ceska Gynekol 2013; 78:473-480. [PMID: 24313435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
INTRODUCTION Prospective detection of postoperative lymphedema of the lower limbs (LLL) in patients after surgery for vulvar cancer using different examination methods and their comparison. DESIGN Prospective clinical study. SETTING Department of Obstetrics and Gynecology, 2nd Medical Faculty of the Charles University and University Hospital Motol, Prague. METHODS Totally 36 women were followed after surgery for vulvar cancer. Due to the radicality of surgery the patients were divided into conservative (sentinel lymph node biopsy) and radical (inguinofemoral lymphadenectomy) group. Lower limbs were preoperatively and 3, 6 and 12 months after surgery assessed for the presence of lymphedema by measuring of circumferences, multifrequency bioelectrical impedance analysis (MFBIA) and subjective evaluation of patients. RESULTS The prevalence of lower limb lymphedema 12 months after surgery diagnosed by subjective evaluation reached 19,44%, by circumference measurement 38,89% and with MFBIA 66,67%. The prevalence of lymphedema after inguinofemoral lymphadenectomy diagnosed by circumference measurement was in 12 months after surgery higher (45.83%) than after the conservative surgery (25%). Risk factors were evaluated 12 months after surgery (age, BMI, adjuvant radiotherapy, type of surgery) and none of them were found to be statistically significant for the development of the lower limbs lymphedema. CONCLUSION The prevalence of lymphedema significantly depends on the diagnostic method, because they capture lymphedema in its various stages. Due to the high sensitivity MFBIA can be used for the detection of early stages of lymphedema. Preoperative measurement of the lower limbs is important for early detection of postoperative lymphedema.
Collapse
|
20
|
Hanulíková P, Vlk R, Meluzínová E, Hynčicová E, Binder T, Chmel R, Rob L. [Pregnancy and multiple sclerosis -outcomes analysis 2003-2011]. Ceska Gynekol 2013; 78:142-148. [PMID: 23710978] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
OBJECTIVE The analysis of perinatal results in pregnant women with multiple sclerosis (MS) and the assessment of the influence of pregnancy on this chronic disease in the population of pregnant women in our hospital in the years 2003-2011. DESIGN Retrospective analysis. SETTING Department of Obstetrics and Gynecology and Department of Neurology, 2nd Faculty of Medicine, Charles University and the Motol Hospital, Prague. METHODS Sixty-six women with the diagnosis of MS were included in our study in the years 2003-2011. All these women delivered at our clinic and were neurologically followed until the end of six months post partum. We evaluated the influence of pregnancy on the activity of the disease during the pregnancy and 6 months after delivery, the impact on the disability progression, the influence of the mode of delivery, the analgesia used, and breastfeeding, on the relapse rate post partum. We also assessed the impact of multiple sclerosis on the course of the pregnancy, where we looked for pregnancy complications in patients with multiple sclerosis, differences in the management of labor, and the results of newborns of mothers with this disease. We performed a statistical analysis. RESULTS Relapse during pregnancy occurred in 4 of the 66 women (6.1%, relapse rate - RR 0.1);17 women experienced a post partum relapse in the first six months after delivery (25.7%, RR 0.5). From our sample of 44 women breastfed (66.7%), 10 had relapse (10/44, 22.7%) in comparison with the 7 women out of a total of 22 who did not breastfed (7/22, 31.8%). No statistical significance was established, OR = 0.6 (0.2-2.0), p = 0.5518. Epidural analgesia (EDA) was used by 16 women (24.2%). Post partum relapse experienced 3 women that used EDA (3/16, 18.8%) and 14 women that did not use EDA (14/50, 28 %). OR = 0.6 (0.1-2.4), p = 0.5325. Neither breastfeeding, nor epidural analgesia correlated with presence of a post partum relapse. Pregnancy did not influence disability progression, EDSS (Disability status scale, Kurtzke`s scale) before pregnancy and after delivery was stable (EDSS 1.5 or EDSS 1.6). Vaginal delivery had 77% women, post partum relapse had 15 of them (15/50, 30%), 12 women (18.1%) had a caesarean section, relapse occure at 2 of them (2/16, 12.5%), three births (4.5%) were completed by vaginal extraction operations. Five women (7.6%) delivered before 37th week of pregnancy. Birth weight under 2500 g was found in 9 women (13.6%). The incidence of serious pregnancy complications was not increased, intrauterine growth retardation (IUGR) was confirmed in 4 births (6%). CONCLUSION There is no need to worry about pregnancy in patients with multiple sclerosis. Therapy provides long-term remission of the disease, and during pregnancy itself due to hormonal changes it is stabilized and the relapse rate decreases. In the post partum period relapse rate increases, however, the pregnancy did not influence disability progression. The mode of delivery in women with this disease is not different from the general population. Neither breastfeeding, nor epidural analgesia correlated with presence of a post partum relapses. The number of complications in pregnancy is not increased and the overall perinatal outcomes are comparable with the general population.
Collapse
Affiliation(s)
- P Hanulíková
- Gynekologicko-porodnická 2. LF UK a FN Motol, Praha, Prednosta prof. MUDr. L Rob, CSc.
| | | | | | | | | | | | | |
Collapse
|
21
|
Abramowski A, Acero F, Aharonian F, Akhperjanian AG, Anton G, Balenderan S, Balzer A, Barnacka A, Becherini Y, Becker Tjus J, Bernlöhr K, Birsin E, Biteau J, Bochow A, Boisson C, Bolmont J, Bordas P, Brucker J, Brun F, Brun P, Bulik T, Carrigan S, Casanova S, Cerruti M, Chadwick PM, Chaves RCG, Cheesebrough A, Colafrancesco S, Cologna G, Conrad J, Couturier C, Dalton M, Daniel MK, Davids ID, Degrange B, Deil C, deWilt P, Dickinson HJ, Djannati-Ataï A, Domainko W, Drury LO, Dubus G, Dutson K, Dyks J, Dyrda M, Egberts K, Eger P, Espigat P, Fallon L, Farnier C, Fegan S, Feinstein F, Fernandes MV, Fernandez D, Fiasson A, Fontaine G, Förster A, Füßling M, Gajdus M, Gallant YA, Garrigoux T, Gast H, Giebels B, Glicenstein JF, Glück B, Göring D, Grondin MH, Häffner S, Hague JD, Hahn J, Hampf D, Harris J, Heinz S, Heinzelmann G, Henri G, Hermann G, Hillert A, Hinton JA, Hofmann W, Hofverberg P, Holler M, Horns D, Jacholkowska A, Jahn C, Jamrozy M, Jung I, Kastendieck MA, Katarzyński K, Katz U, Kaufmann S, Khélifi B, Klepser S, Klochkov D, Kluźniak W, Kneiske T, Komin N, Kosack K, Kossakowski R, Krayzel F, Krüger PP, Laffon H, Lamanna G, Lefaucheur J, Lemoine-Goumard M, Lenain JP, Lennarz D, Lohse T, Lopatin A, Lu CC, Marandon V, Marcowith A, Masbou J, Maurin G, Maxted N, Mayer M, McComb TJL, Medina MC, Méhault J, Menzler U, Moderski R, Mohamed M, Moulin E, Naumann CL, Naumann-Godo M, de Naurois M, Nedbal D, Nekrassov D, Nguyen N, Niemiec J, Nolan SJ, Ohm S, de Oña Wilhelmi E, Opitz B, Ostrowski M, Oya I, Panter M, Parsons RD, Paz Arribas M, Pekeur NW, Pelletier G, Perez J, Petrucci PO, Peyaud B, Pita S, Pühlhofer G, Punch M, Quirrenbach A, Raue M, Reimer A, Reimer O, Renaud M, de Los Reyes R, Rieger F, Ripken J, Rob L, Rosier-Lees S, Rowell G, Rudak B, Rulten CB, Sahakian V, Sanchez DA, Santangelo A, Schlickeiser R, Schulz A, Schwanke U, Schwarzburg S, Schwemmer S, Sheidaei F, Skilton JL, Sol H, Spengler G, Stawarz L, Steenkamp R, Stegmann C, Stinzing F, Stycz K, Sushch I, Szostek A, Tavernet JP, Terrier R, Tluczykont M, Trichard C, Valerius K, van Eldik C, Vasileiadis G, Venter C, Viana A, Vincent P, Völk HJ, Volpe F, Vorobiov S, Vorster M, Wagner SJ, Ward M, White R, Wierzcholska A, Wouters D, Zacharias M, Zajczyk A, Zdziarski AA, Zech A, Zechlin HS. Search for photon-linelike signatures from dark matter annihilations with H.E.S.S. Phys Rev Lett 2013; 110:041301. [PMID: 25166149 DOI: 10.1103/physrevlett.110.041301] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/15/2012] [Indexed: 06/03/2023]
Abstract
Gamma-ray line signatures can be expected in the very-high-energy (E(γ)>100 GeV) domain due to self-annihilation or decay of dark matter (DM) particles in space. Such a signal would be readily distinguishable from astrophysical γ-ray sources that in most cases produce continuous spectra that span over several orders of magnitude in energy. Using data collected with the H.E.S.S. γ-ray instrument, upper limits on linelike emission are obtained in the energy range between ∼ 500 GeV and ∼ 25 TeV for the central part of the Milky Way halo and for extragalactic observations, complementing recent limits obtained with the Fermi-LAT instrument at lower energies. No statistically significant signal could be found. For monochromatic γ-ray line emission, flux limits of (2 × 10(-7) -2 × 10(-5)) m(-2) s(-1) sr(-1) and (1 × 10(-8) -2 × 10(-6)) m(-2) s(-1)sr(-1) are obtained for the central part of the Milky Way halo and extragalactic observations, respectively. For a DM particle mass of 1 TeV, limits on the velocity-averaged DM annihilation cross section ⟨σv⟩(χχ → γγ) reach ∼ 10(-27) cm(3)s(-1), based on the Einasto parametrization of the Galactic DM halo density profile.
Collapse
Affiliation(s)
- A Abramowski
- Universität Hamburg, Institut für Experimentalphysik, Luruper Chaussee 149, D 22761 Hamburg, Germany
| | - F Acero
- Laboratoire Univers et Particules de Montpellier, Université Montpellier 2, CNRS/IN2P3, CC 72, Place Eugène Bataillon, F-34095 Montpellier Cedex 5, France
| | - F Aharonian
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany and Dublin Institute for Advanced Studies, 31 Fitzwilliam Place, Dublin 2, Ireland and National Academy of Sciences of the Republic of Armenia, Armenia, Yerevan
| | - A G Akhperjanian
- National Academy of Sciences of the Republic of Armenia, Armenia, Yerevan and Yerevan Physics Institute, 2 Alikhanian Brothers Street, 375036 Yerevan, Armenia
| | - G Anton
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - S Balenderan
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, United Kingdom
| | - A Balzer
- DESY, D-15735 Zeuthen, Germany and Institut für Physik und Astronomie, Universität Potsdam, Karl-Liebknecht-Strasse 24/25, D 14476 Potsdam, Germany
| | - A Barnacka
- Nicolaus Copernicus Astronomical Center, ulica Bartycka 18, 00-716 Warsaw, Poland and CEA Saclay, DSM/Irfu, F-91191 Gif-Sur-Yvette Cedex, France
| | - Y Becherini
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France, and Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | - J Becker Tjus
- Institut für Theoretische Physik, Lehrstuhl IV: Weltraum und Astrophysik, Ruhr-Universität Bochum, D 44780 Bochum, Germany
| | - K Bernlöhr
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany and Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany
| | - E Birsin
- Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany
| | - J Biteau
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | - A Bochow
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - C Boisson
- LUTH, Observatoire de Paris, CNRS, Université Paris Diderot, 5 Place Jules Janssen, 92190 Meudon, France
| | - J Bolmont
- LPNHE, Université Pierre et Marie Curie Paris 6, Université Denis Diderot Paris 7, CNRS/IN2P3, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - P Bordas
- Institut für Astronomie und Astrophysik, Universität Tübingen, Sand 1, D 72076 Tübingen, Germany
| | - J Brucker
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - F Brun
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | - P Brun
- CEA Saclay, DSM/Irfu, F-91191 Gif-Sur-Yvette Cedex, France
| | - T Bulik
- Astronomical Observatory, The University of Warsaw, Aleje Ujazdowskie 4, 00-478 Warsaw, Poland
| | - S Carrigan
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - S Casanova
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany and Unit for Space Physics, North-West University, Potchefstroom 2520, South Africa
| | - M Cerruti
- LUTH, Observatoire de Paris, CNRS, Université Paris Diderot, 5 Place Jules Janssen, 92190 Meudon, France
| | - P M Chadwick
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, United Kingdom
| | - R C G Chaves
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany and CEA Saclay, DSM/Irfu, F-91191 Gif-Sur-Yvette Cedex, France
| | - A Cheesebrough
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, United Kingdom
| | - S Colafrancesco
- School of Physics, University of the Witwatersrand, 1 Jan Smuts Avenue, Braamfontein, Johannesburg, 2050 South Africa
| | - G Cologna
- Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
| | - J Conrad
- Oskar Klein Centre, Department of Physics, Stockholm University, Albanova University Center, SE-10691 Stockholm, Sweden
| | - C Couturier
- LPNHE, Université Pierre et Marie Curie Paris 6, Université Denis Diderot Paris 7, CNRS/IN2P3, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - M Dalton
- Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany and Université Bordeaux 1, CNRS/IN2P3, Centre d'Études Nucléaires de Bordeaux Gradignan, 33175 Gradignan, France
| | - M K Daniel
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, United Kingdom
| | - I D Davids
- University of Namibia, Department of Physics, Private Bag 13301, Windhoek, Namibia
| | - B Degrange
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | - C Deil
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - P deWilt
- School of Chemistry and Physics, University of Adelaide, Adelaide 5005, Australia
| | - H J Dickinson
- Oskar Klein Centre, Department of Physics, Stockholm University, Albanova University Center, SE-10691 Stockholm, Sweden
| | - A Djannati-Ataï
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - W Domainko
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - L O'C Drury
- Dublin Institute for Advanced Studies, 31 Fitzwilliam Place, Dublin 2, Ireland
| | - G Dubus
- UJF-Grenoble 1/CNRS-INSU, Institut de Planétologie et d'Astrophysique de Grenoble (IPAG) UMR 5274, Grenoble, F-38041, France
| | - K Dutson
- Department of Physics and Astronomy, The University of Leicester, University Road, Leicester, LE1 7RH, United Kingdom
| | - J Dyks
- Nicolaus Copernicus Astronomical Center, ulica Bartycka 18, 00-716 Warsaw, Poland
| | - M Dyrda
- Instytut Fizyki Ja̧drowej PAN, ulica Radzikowskiego 152, 31-342 Kraków, Poland
| | - K Egberts
- Institut für Astro- und Teilchenphysik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - P Eger
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - P Espigat
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - L Fallon
- Dublin Institute for Advanced Studies, 31 Fitzwilliam Place, Dublin 2, Ireland
| | - C Farnier
- Oskar Klein Centre, Department of Physics, Stockholm University, Albanova University Center, SE-10691 Stockholm, Sweden
| | - S Fegan
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | - F Feinstein
- Laboratoire Univers et Particules de Montpellier, Université Montpellier 2, CNRS/IN2P3, CC 72, Place Eugène Bataillon, F-34095 Montpellier Cedex 5, France
| | - M V Fernandes
- Universität Hamburg, Institut für Experimentalphysik, Luruper Chaussee 149, D 22761 Hamburg, Germany
| | - D Fernandez
- Laboratoire Univers et Particules de Montpellier, Université Montpellier 2, CNRS/IN2P3, CC 72, Place Eugène Bataillon, F-34095 Montpellier Cedex 5, France
| | - A Fiasson
- Laboratoire d'Annecy-le-Vieux de Physique des Particules, Université de Savoie, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - G Fontaine
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | - A Förster
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - M Füßling
- Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany
| | - M Gajdus
- Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany
| | - Y A Gallant
- Laboratoire Univers et Particules de Montpellier, Université Montpellier 2, CNRS/IN2P3, CC 72, Place Eugène Bataillon, F-34095 Montpellier Cedex 5, France
| | - T Garrigoux
- LPNHE, Université Pierre et Marie Curie Paris 6, Université Denis Diderot Paris 7, CNRS/IN2P3, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - H Gast
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - B Giebels
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | | | - B Glück
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - D Göring
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - M-H Grondin
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany and Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
| | - S Häffner
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - J D Hague
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - J Hahn
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - D Hampf
- Universität Hamburg, Institut für Experimentalphysik, Luruper Chaussee 149, D 22761 Hamburg, Germany
| | - J Harris
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, United Kingdom
| | - S Heinz
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - G Heinzelmann
- Universität Hamburg, Institut für Experimentalphysik, Luruper Chaussee 149, D 22761 Hamburg, Germany
| | - G Henri
- UJF-Grenoble 1/CNRS-INSU, Institut de Planétologie et d'Astrophysique de Grenoble (IPAG) UMR 5274, Grenoble, F-38041, France
| | - G Hermann
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - A Hillert
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - J A Hinton
- Department of Physics and Astronomy, The University of Leicester, University Road, Leicester, LE1 7RH, United Kingdom
| | - W Hofmann
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - P Hofverberg
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - M Holler
- Institut für Physik und Astronomie, Universität Potsdam, Karl-Liebknecht-Strasse 24/25, D 14476 Potsdam, Germany
| | - D Horns
- Universität Hamburg, Institut für Experimentalphysik, Luruper Chaussee 149, D 22761 Hamburg, Germany
| | - A Jacholkowska
- LPNHE, Université Pierre et Marie Curie Paris 6, Université Denis Diderot Paris 7, CNRS/IN2P3, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - C Jahn
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - M Jamrozy
- Obserwatorium Astronomiczne, Uniwersytet Jagielloński, ulica Orla 171, 30-244 Kraków, Poland
| | - I Jung
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - M A Kastendieck
- Universität Hamburg, Institut für Experimentalphysik, Luruper Chaussee 149, D 22761 Hamburg, Germany
| | - K Katarzyński
- Toruń Centre for Astronomy, Nicolaus Copernicus University, ulica Gagarina 11, 87-100 Toruń, Poland
| | - U Katz
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - S Kaufmann
- Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
| | - B Khélifi
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | | | - D Klochkov
- Institut für Astronomie und Astrophysik, Universität Tübingen, Sand 1, D 72076 Tübingen, Germany
| | - W Kluźniak
- Nicolaus Copernicus Astronomical Center, ulica Bartycka 18, 00-716 Warsaw, Poland
| | - T Kneiske
- Universität Hamburg, Institut für Experimentalphysik, Luruper Chaussee 149, D 22761 Hamburg, Germany
| | - Nu Komin
- Laboratoire d'Annecy-le-Vieux de Physique des Particules, Université de Savoie, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - K Kosack
- CEA Saclay, DSM/Irfu, F-91191 Gif-Sur-Yvette Cedex, France
| | - R Kossakowski
- Laboratoire d'Annecy-le-Vieux de Physique des Particules, Université de Savoie, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - F Krayzel
- Laboratoire d'Annecy-le-Vieux de Physique des Particules, Université de Savoie, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - P P Krüger
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany and Unit for Space Physics, North-West University, Potchefstroom 2520, South Africa
| | - H Laffon
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | - G Lamanna
- Laboratoire d'Annecy-le-Vieux de Physique des Particules, Université de Savoie, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - J Lefaucheur
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - M Lemoine-Goumard
- Université Bordeaux 1, CNRS/IN2P3, Centre d'Études Nucléaires de Bordeaux Gradignan, 33175 Gradignan, France
| | - J-P Lenain
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - D Lennarz
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - T Lohse
- Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany
| | - A Lopatin
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - C-C Lu
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - V Marandon
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - A Marcowith
- Laboratoire Univers et Particules de Montpellier, Université Montpellier 2, CNRS/IN2P3, CC 72, Place Eugène Bataillon, F-34095 Montpellier Cedex 5, France
| | - J Masbou
- Laboratoire d'Annecy-le-Vieux de Physique des Particules, Université de Savoie, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - G Maurin
- Laboratoire d'Annecy-le-Vieux de Physique des Particules, Université de Savoie, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - N Maxted
- School of Chemistry and Physics, University of Adelaide, Adelaide 5005, Australia
| | - M Mayer
- Institut für Physik und Astronomie, Universität Potsdam, Karl-Liebknecht-Strasse 24/25, D 14476 Potsdam, Germany
| | - T J L McComb
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, United Kingdom
| | - M C Medina
- CEA Saclay, DSM/Irfu, F-91191 Gif-Sur-Yvette Cedex, France
| | - J Méhault
- Laboratoire Univers et Particules de Montpellier, Université Montpellier 2, CNRS/IN2P3, CC 72, Place Eugène Bataillon, F-34095 Montpellier Cedex 5, France and Université Bordeaux 1, CNRS/IN2P3, Centre d'Études Nucléaires de Bordeaux Gradignan, 33175 Gradignan, France
| | - U Menzler
- Institut für Theoretische Physik, Lehrstuhl IV: Weltraum und Astrophysik, Ruhr-Universität Bochum, D 44780 Bochum, Germany
| | - R Moderski
- Nicolaus Copernicus Astronomical Center, ulica Bartycka 18, 00-716 Warsaw, Poland
| | - M Mohamed
- Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
| | - E Moulin
- CEA Saclay, DSM/Irfu, F-91191 Gif-Sur-Yvette Cedex, France
| | - C L Naumann
- LPNHE, Université Pierre et Marie Curie Paris 6, Université Denis Diderot Paris 7, CNRS/IN2P3, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - M Naumann-Godo
- CEA Saclay, DSM/Irfu, F-91191 Gif-Sur-Yvette Cedex, France
| | - M de Naurois
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | - D Nedbal
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, V Holešovičkách 2, 180 00 Prague 8, Czech Republic
| | - D Nekrassov
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - N Nguyen
- Universität Hamburg, Institut für Experimentalphysik, Luruper Chaussee 149, D 22761 Hamburg, Germany
| | - J Niemiec
- Instytut Fizyki Ja̧drowej PAN, ulica Radzikowskiego 152, 31-342 Kraków, Poland
| | - S J Nolan
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, United Kingdom
| | - S Ohm
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany and Department of Physics and Astronomy, The University of Leicester, University Road, Leicester, LE1 7RH, United Kingdom
| | - E de Oña Wilhelmi
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - B Opitz
- Universität Hamburg, Institut für Experimentalphysik, Luruper Chaussee 149, D 22761 Hamburg, Germany
| | - M Ostrowski
- Obserwatorium Astronomiczne, Uniwersytet Jagielloński, ulica Orla 171, 30-244 Kraków, Poland
| | - I Oya
- Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany
| | - M Panter
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - R D Parsons
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - M Paz Arribas
- Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany
| | - N W Pekeur
- Unit for Space Physics, North-West University, Potchefstroom 2520, South Africa
| | - G Pelletier
- UJF-Grenoble 1/CNRS-INSU, Institut de Planétologie et d'Astrophysique de Grenoble (IPAG) UMR 5274, Grenoble, F-38041, France
| | - J Perez
- Institut für Astro- und Teilchenphysik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - P-O Petrucci
- UJF-Grenoble 1/CNRS-INSU, Institut de Planétologie et d'Astrophysique de Grenoble (IPAG) UMR 5274, Grenoble, F-38041, France
| | - B Peyaud
- CEA Saclay, DSM/Irfu, F-91191 Gif-Sur-Yvette Cedex, France
| | - S Pita
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - G Pühlhofer
- Institut für Astronomie und Astrophysik, Universität Tübingen, Sand 1, D 72076 Tübingen, Germany
| | - M Punch
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - A Quirrenbach
- Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
| | - M Raue
- Universität Hamburg, Institut für Experimentalphysik, Luruper Chaussee 149, D 22761 Hamburg, Germany
| | - A Reimer
- Institut für Astro- und Teilchenphysik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - O Reimer
- Institut für Astro- und Teilchenphysik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - M Renaud
- Laboratoire Univers et Particules de Montpellier, Université Montpellier 2, CNRS/IN2P3, CC 72, Place Eugène Bataillon, F-34095 Montpellier Cedex 5, France
| | - R de Los Reyes
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - F Rieger
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - J Ripken
- Oskar Klein Centre, Department of Physics, Stockholm University, Albanova University Center, SE-10691 Stockholm, Sweden
| | - L Rob
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, V Holešovičkách 2, 180 00 Prague 8, Czech Republic
| | - S Rosier-Lees
- Laboratoire d'Annecy-le-Vieux de Physique des Particules, Université de Savoie, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - G Rowell
- School of Chemistry and Physics, University of Adelaide, Adelaide 5005, Australia
| | - B Rudak
- Nicolaus Copernicus Astronomical Center, ulica Bartycka 18, 00-716 Warsaw, Poland
| | - C B Rulten
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, United Kingdom
| | - V Sahakian
- National Academy of Sciences of the Republic of Armenia, Armenia, Yerevan and Yerevan Physics Institute, 2 Alikhanian Brothers Street, 375036 Yerevan, Armenia
| | - D A Sanchez
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - A Santangelo
- Institut für Astronomie und Astrophysik, Universität Tübingen, Sand 1, D 72076 Tübingen, Germany
| | - R Schlickeiser
- Institut für Theoretische Physik, Lehrstuhl IV: Weltraum und Astrophysik, Ruhr-Universität Bochum, D 44780 Bochum, Germany
| | | | - U Schwanke
- Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany
| | - S Schwarzburg
- Institut für Astronomie und Astrophysik, Universität Tübingen, Sand 1, D 72076 Tübingen, Germany
| | - S Schwemmer
- Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
| | - F Sheidaei
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France, and Unit for Space Physics, North-West University, Potchefstroom 2520, South Africa
| | - J L Skilton
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - H Sol
- LUTH, Observatoire de Paris, CNRS, Université Paris Diderot, 5 Place Jules Janssen, 92190 Meudon, France
| | - G Spengler
- Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany
| | - L Stawarz
- Obserwatorium Astronomiczne, Uniwersytet Jagielloński, ulica Orla 171, 30-244 Kraków, Poland
| | - R Steenkamp
- University of Namibia, Department of Physics, Private Bag 13301, Windhoek, Namibia
| | - C Stegmann
- DESY, D-15735 Zeuthen, Germany and Institut für Physik und Astronomie, Universität Potsdam, Karl-Liebknecht-Strasse 24/25, D 14476 Potsdam, Germany
| | - F Stinzing
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - K Stycz
- DESY, D-15735 Zeuthen, Germany
| | - I Sushch
- Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany
| | - A Szostek
- Obserwatorium Astronomiczne, Uniwersytet Jagielloński, ulica Orla 171, 30-244 Kraków, Poland
| | - J-P Tavernet
- LPNHE, Université Pierre et Marie Curie Paris 6, Université Denis Diderot Paris 7, CNRS/IN2P3, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - R Terrier
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - M Tluczykont
- Universität Hamburg, Institut für Experimentalphysik, Luruper Chaussee 149, D 22761 Hamburg, Germany
| | - C Trichard
- Laboratoire d'Annecy-le-Vieux de Physique des Particules, Université de Savoie, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - K Valerius
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - C van Eldik
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany and Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - G Vasileiadis
- Laboratoire Univers et Particules de Montpellier, Université Montpellier 2, CNRS/IN2P3, CC 72, Place Eugène Bataillon, F-34095 Montpellier Cedex 5, France
| | - C Venter
- Unit for Space Physics, North-West University, Potchefstroom 2520, South Africa
| | - A Viana
- CEA Saclay, DSM/Irfu, F-91191 Gif-Sur-Yvette Cedex, France
| | - P Vincent
- LPNHE, Université Pierre et Marie Curie Paris 6, Université Denis Diderot Paris 7, CNRS/IN2P3, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - H J Völk
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - F Volpe
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - S Vorobiov
- Laboratoire Univers et Particules de Montpellier, Université Montpellier 2, CNRS/IN2P3, CC 72, Place Eugène Bataillon, F-34095 Montpellier Cedex 5, France
| | - M Vorster
- Unit for Space Physics, North-West University, Potchefstroom 2520, South Africa
| | - S J Wagner
- Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
| | - M Ward
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, United Kingdom
| | - R White
- Department of Physics and Astronomy, The University of Leicester, University Road, Leicester, LE1 7RH, United Kingdom
| | - A Wierzcholska
- Obserwatorium Astronomiczne, Uniwersytet Jagielloński, ulica Orla 171, 30-244 Kraków, Poland
| | - D Wouters
- CEA Saclay, DSM/Irfu, F-91191 Gif-Sur-Yvette Cedex, France
| | - M Zacharias
- Institut für Theoretische Physik, Lehrstuhl IV: Weltraum und Astrophysik, Ruhr-Universität Bochum, D 44780 Bochum, Germany
| | - A Zajczyk
- Laboratoire Univers et Particules de Montpellier, Université Montpellier 2, CNRS/IN2P3, CC 72, Place Eugène Bataillon, F-34095 Montpellier Cedex 5, France and Nicolaus Copernicus Astronomical Center, ulica Bartycka 18, 00-716 Warsaw, Poland
| | - A A Zdziarski
- Nicolaus Copernicus Astronomical Center, ulica Bartycka 18, 00-716 Warsaw, Poland
| | - A Zech
- LUTH, Observatoire de Paris, CNRS, Université Paris Diderot, 5 Place Jules Janssen, 92190 Meudon, France
| | - H-S Zechlin
- Universität Hamburg, Institut für Experimentalphysik, Luruper Chaussee 149, D 22761 Hamburg, Germany
| |
Collapse
|
22
|
Brtnicky T, Podrazil M, Bartunkova J, Spíšek R, Rob L. [Active cellular immunotherapy of ovarian cancer using dendritic cells]. Ceska Gynekol 2012; 77:215-220. [PMID: 22779721] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
OBJECTIVE Overview and comparison of current results of studies dealing with the development and application of anti-cancer vaccines based on dendritic cells in ovarian cancer. DESIGN Review. SETTING Department of Obstetrics and Gynaecology Charles University, Prague, 2nd Faculty of Medicine and University Hospital Motol, Department of Immunology 2nd Faculty of Medicine and University Hospital Motol. SUMMARY Ovarian carcinoma (OVCA) is highly sensitive to chemotherapy; however despite this results from treatment are fairly unsatisfactory. Bearing this in mind, it is important to look for new ways to better understand the immunological mechanisms which could affect reactivation of the disease. It is likely that new knowledge in the field of the immunology of ovarian carcinoma could improve monitoring of the disease and help to ameliorate prognosis of the disease. One strategy in development is creation of anti-OVCA vaccines. Theese vaccines are made by the fusion of dendritic cell (DC) and tumor cells or its parts (NA, peptides). DC are bone-marrow derived leukocytes that are critical in the initiation of T cell mediated immunity. DC are fused to patient-derived ovarian carcinoma cells. The fusion cells induces cytotoxic T cell against autologous OVCA cells.
Collapse
|
23
|
Rob L, Robová H, Chmel R, Skapa P. [Gynaecological precanceroses from the clinical perspective - today and tomorrow]. Cesk Patol 2012; 48:9-14. [PMID: 22716002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
During the last twenty-five years an enormous shift in our knowledge of cancerogenesis in all gynaecological precancerous and cancerous diseases can be seen. Early diagnosis of these lesions of the lower genital tract (vulva, vagina and cervix) is enabled mainly due to easy access. The major role in the pathogenesis of most precancerous lesions can be accounted to high risk human papillomavirus. Recently, new information about HPV genotypisation of single precancerous lesions and single histological cancer types were revealed. Thus we can better estimate the effect of vaccines on different age groups of women in relation to different types of cancer. The development and introduction of prophylactic vaccines into clinical practice was one of the major improvements of current medicine. Precancerous and cancer lesions of endometrium make themselves known by early symptoms such as perimenopausal and postmenopausal bleeding. Optimal diagnostic and therapeutic procedures have to be based on close cooperation between the clinician and pathologist.
Collapse
Affiliation(s)
- L Rob
- Gynekologikcko porodnicka klinika UK.
| | | | | | | |
Collapse
|
24
|
Skapa P, Robová H, Rob L, Zámečník J. [Review of precancerous vulvar lesions]. Cesk Patol 2012; 48:15-21. [PMID: 22716003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Classification of squamous vulvar precancerous lesions is based on the concept of vulvar intraepithelial neoplasia (VIN) and incorporates a three grade evaluation of the intensity of dysplastic changes (VIN I, II and III). On the basis of histological features, VIN has been subdivided into the usual VIN (u-VIN) and differentiated VIN (d-VIN), which represent the two basic pathways of the pathogenesis of vulvar squamous cell carcinoma. Although u-VIN is etiologically associated with the human papillomavirus (HPV) infection and histologically corresponds to cervical intraepithelial neoplasia, d-VIN represents the HPV-negative sequence of vulvar carcinogenesis, which is linked to lichen sclerosus (LS) and lichen simplex chronicus (LSC). u-VIN preferentially occurs in relatively young women with a history of cervical, vaginal or vulvar premalignant lesions. On the other hand, d-VIN usually affects postmenopausal women without anamnestic data of other dysplastic lesions of the lower female genital tract. d-VIN is characterized by a higher tendency of stromal invasion than u-VIN and its malignant potential is analogous to carcinoma in situ (VIN III). The histological appearance of d-VIN is subtle with basal atypia and a well-preserved differentiation of the superficial parts of the squamous epithelium, therefore it is frequently misdiagnosed for u-VIN I, LS or LSC in vulvar biopsies. Primarily because of the low diagnostic reproducibility of the u-VIN I category and the doubts about its precancerous potential as well as due to the questionable differentiation between u-VIN II and III, a revised VIN classification was proposed in 2004. The grading of vulvar precancerous lesions was abandoned, the u-VIN I category was discontinued and u-VIN II and III were merged. In the revised terminology, the term u-VIN represents HPV-associated high grade precancerous vulvar lesions (formerly u-VIN II and III) and d-VIN encompasses HPV-negative high grade dysplasias.
Collapse
Affiliation(s)
- P Skapa
- Ustav patologie a molekularni mediciny UK, Praha, Ceska Republika.
| | | | | | | |
Collapse
|
25
|
Svoboda B, Líbalová P, Kubecová M, Rob L, Freitag P, Pilka RS, Chovanec J, Tikovský K, Vernerová Z. [Guideline for treatment of gynaecological malignant tumours 2010---endometrial carcinoma]. Ceska Gynekol 2011; 76:208-215. [PMID: 21838152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
OBJECTIVE To develop guideline for primary surgical treatment of endometrial carcinoma. DESIGN Review, consensus of expert group. SETTING Dept. of Gynaecology and Obstetrics, 3rd Medical Faculty of Charles University in Prague. METHOD A retrospective review of published data, analysis of statistic data from Czech Republic, consensus among proposers and opponents. RESULTS The guideline recognizes endometrial carcinoma patients based on their risk and recommends type of surgical treatment for certain group. It emphasizes the importance of centralized oncogynaecological treatment. Surgical staging remains the basic principle for treatment of endometrial carcinoma patients. The aim of pre-operative diagnostics is to estimate the extent of the disease--"interim staging", that can be different from definitive histopathological staging. Based on risk factors patients are divided into low or high risk group. Standard procedure for low risk patients is hysterectomy and bilateral salpingoophorectomy. It is advisable to use peroperative biopsy in these patients that can shift the patient to high risk group. High risk patients are recommended for hysterectomy, bilateral salpingoophorectomy, and systematic aortopelvic lymphadenectomy. The guideline contains recommendation for young patients wishing to preserve their fertility, for cases of inadequate surgery and for follow-up. CONCLUSION Guideline for treatment of endometrial carcinoma is recommendation for clinicians and other subjects who participate on the process of the diagnostics/treatment of endometrial carcinoma patients. All points of the guideline were discussed and voted about by all participants of expert group.
Collapse
Affiliation(s)
- B Svoboda
- Gynekologicko-porodnická klinika 3. LF UK a FN KV, Praha
| | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Abramowski A, Acero F, Aharonian F, Akhperjanian AG, Anton G, Barnacka A, de Almeida UB, Bazer-Bachi AR, Becherini Y, Becker J, Behera B, Bernlöhr K, Bochow A, Boisson C, Bolmont J, Bordas P, Borrel V, Brucker J, Brun F, Brun P, Bulik T, Büsching I, Carrigan S, Casanova S, Cerruti M, Chadwick PM, Charbonnier A, Chaves RCG, Cheesebrough A, Chounet LM, Clapson AC, Coignet G, Conrad J, Dalton M, Daniel MK, Davids ID, Degrange B, Deil C, Dickinson HJ, Djannati-Ataï A, Domainko W, Drury LO, Dubois F, Dubus G, Dyks J, Dyrda M, Egberts K, Eger P, Espigat P, Fallon L, Farnier C, Fegan S, Feinstein F, Fernandes MV, Fiasson A, Fontaine G, Förster A, Füssling M, Gallant YA, Gast H, Gérard L, Gerbig D, Giebels B, Glicenstein JF, Glück B, Goret P, Göring D, Hague JD, Hampf D, Hauser M, Heinz S, Heinzelmann G, Henri G, Hermann G, Hinton JA, Hoffmann A, Hofmann W, Hofverberg P, Horns D, Jacholkowska A, de Jager OC, Jahn C, Jamrozy M, Jung I, Kastendieck MA, Katarzyński K, Katz U, Kaufmann S, Keogh D, Kerschhaggl M, Khangulyan D, Khélifi B, Klochkov D, Kluźniak W, Kneiske T, Komin N, Kosack K, Kossakowski R, Laffon H, Lamanna G, Lennarz D, Lohse T, Lopatin A, Lu CC, Marandon V, Marcowith A, Masbou J, Maurin D, Maxted N, McComb TJL, Medina MC, Méhault J, Moderski R, Moulin E, Naumann CL, Naumann-Godo M, de Naurois M, Nedbal D, Nekrassov D, Nguyen N, Nicholas B, Niemiec J, Nolan SJ, Ohm S, Olive JF, Wilhelmi EDO, Opitz B, Ostrowski M, Panter M, Arribas MP, Pedaletti G, Pelletier G, Petrucci PO, Pita S, Pühlhofer G, Punch M, Quirrenbach A, Raue M, Rayner SM, Reimer A, Reimer O, Renaud M, de los Reyes R, Rieger F, Ripken J, Rob L, Rosier-Lees S, Rowell G, Rudak B, Rulten CB, Ruppel J, Ryde F, Sahakian V, Santangelo A, Schlickeiser R, Schöck FM, Schönwald A, Schwanke U, Schwarzburg S, Schwemmer S, Shalchi A, Sikora M, Skilton JL, Sol H, Spengler G, Stawarz Ł, Steenkamp R, Stegmann C, Stinzing F, Sushch I, Szostek A, Tavernet JP, Terrier R, Tibolla O, Tluczykont M, Valerius K, van Eldik C, Vasileiadis G, Venter C, Vialle JP, Viana A, Vincent P, Vivier M, Völk HJ, Volpe F, Vorobiov S, Vorster M, Wagner SJ, Ward M, Wierzcholska A, Zajczyk A, Zdziarski AA, Zech A, Zechlin HS. Search for a dark matter annihilation signal from the galactic center halo with H.E.S.S. Phys Rev Lett 2011; 106:161301. [PMID: 21599352 DOI: 10.1103/physrevlett.106.161301] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/04/2010] [Revised: 01/12/2011] [Indexed: 05/30/2023]
Abstract
A search for a very-high-energy (VHE; ≥100 GeV) γ-ray signal from self-annihilating particle dark matter (DM) is performed towards a region of projected distance r∼45-150 pc from the Galactic center. The background-subtracted γ-ray spectrum measured with the High Energy Stereoscopic System (H.E.S.S.) γ-ray instrument in the energy range between 300 GeV and 30 TeV shows no hint of a residual γ-ray flux. Assuming conventional Navarro-Frenk-White and Einasto density profiles, limits are derived on the velocity-weighted annihilation cross section (σv) as a function of the DM particle mass. These are among the best reported so far for this energy range and in particular differ only little between the chosen density profile parametrizations. In particular, for the DM particle mass of ∼1 TeV, values for (σv) above 3×10(-25) cm(3) s(-1) are excluded for the Einasto density profile.
Collapse
Affiliation(s)
- A Abramowski
- Universität Hamburg, Institut für Experimentalphysik, Hamburg, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Kotaska K, Urinovska R, Klapkova E, Prusa R, Rob L, Binder T. Re-evaluation of cord blood arterial and venous reference ranges for pH, pO(2), pCO(2), according to spontaneous or cesarean delivery. J Clin Lab Anal 2011; 24:300-4. [PMID: 20872563 DOI: 10.1002/jcla.20405] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Umbilical cord blood gas analysis (pO(2) and pCO(2)) is now recommended in all high-risk baby deliveries and in some centers it is performed routinely following all deliveries. The aim of this study was to re-evaluate cord blood arterial and venous reference ranges for pH, pO(2), pCO(2) in newborns, delivered by spontaneous vaginal delivery (SVD) and by cesarean section (CS) performed in Faculty Hospital Motol. Two groups of subjects were selected for the study. Group I consisted of 303 newborns with SVD. Group II consisted of 189 newborns delivered by cesarean section. Cord blood samples were analyzed for standard blood gas and pH, using the analytical device Rapid Lab 845 and Rapid Lab 865. We obtained reference values expressed as range (lower and upper reference value expressed as 2.5 and 97.5 percentiles) for cord blood in newborns with SVD: arterial cord blood: pH=7.01-7.39; pCO(2)=4.12-11.45 kPa; pO(2)=1.49-5.06 kPa; venous cord blood: pH=7.06-7.44; pCO(2)=3.33-9.85 kPa; pO(2)=1.80-6.29 kPa. We also obtained reference values for cord blood in newborns delivered by CS: arterial cord blood: pH=7.05-7.39; pCO(2)=5.01-10.60 kPa; pO(2)=1.17-5.94 kPa; venous cord blood: pH=7.10-7.42; pCO(2)=3.88-9.36 kPa; pO(2)=1.98-7.23 kPa. Re-evaluated reference ranges play essential role in monitoring conditions of newborns with spontaneous and caesarean delivery.
Collapse
Affiliation(s)
- K Kotaska
- Department of Clinical Biochemistry and Pathobiochemistry, Charles University, 2nd Faculty of Medicine and Faculty Hospital Motol, Prague, Czech Republic.
| | | | | | | | | | | |
Collapse
|
28
|
Halaška MJ, Brtnický T, Novácková M, Pluta M, Stankušová H, Chmel R, Hrehorcák M, Robová H, Rob L. [Czech version of EORTC QLQ-CX24 questionnaire for patients with cervical cancer]. Ceska Gynekol 2010; 75:529-534. [PMID: 27534010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
OBJECTIVE Translation and validation of the EORTC QLQ-CX24 questionnaire on quality of life into the Czech language and literature. TYPE OF STUDY Prospective study. SETTING Dept. of Obstetrics and Gynaecology, 2nd Medical Faculty, Charles University and Faculty Hospital Motol, Prague. METHODS In concordance with the EORTC guidelines a questionaire for patients with cervical cancer was translated and validated. A group of 14 women who underwent the treatment for cervical cancer filled in the questionaire. T-test was used for the evaluation of the patient's characteristics and the differences in quality of life. RESULTS We present a Czech version of the questionaire EORTC QLQ-CX24 and the description how to evaulate it. In comparison of the two treatment groups no statistically significant differences have been found. CONCLUSION EORTC QLQ-CX24 is an internationally accepted questionnaire focused on patients with cervical cancer which should be incorporated into the projects dealing with women undergoing treatment for this disease.
Collapse
|
29
|
Skultéty J, Novácková M, Binder T, Hadacová I, Salaj P, Rob L. [Thrombotic thrombocytopenic purpura in pregnancy. Case report]. Ceska Gynekol 2010; 75:306-308. [PMID: 20925227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
OBJECTIVE Description of case of patient with rare thrombotic thrombocytopenic purpura in pregnancy. SUBJECT Case report. SETTING Department of Gynecology and Obstetrics, Charles University and University Hospital Motol, Prague. CONCLUSION Thrombotic thrombocytopenic purpura (TTP) is a rare and substantial disorder characterized with combination of microangiopathic haemolytic anemia, consumption trombocytopenia and symptoms of organs dysfunction--especially kidneys and neurological deficiency. It's caused by production of microthrombi affecting small blood vessels. These palatelets-rich microtrombi are formed due to deficiency of the enzyme ADAMTS13--metalloprotease which is responsible for cleaving of ultralarge multimers of von Willebrand factor into smaller units. In our case report we describe patient with TTP in pregnancy. Therapy with corticosteroids and immunoglobulines was not effective, improvement of thrombocytopenia appeared after plasmapheresis (total count 14). The delivery was induced at term without complications. Target examination confirmed diagnosis of secondary TTP.
Collapse
Affiliation(s)
- Jirí Skultéty
- Gynekologicko-porodnická klinika 2. LF UK a FN Motol, Praha.
| | | | | | | | | | | |
Collapse
|
30
|
Suchová K, Obrtlíková P, Binder T, Halaska M, Feldmár P, Spálová I, Sucharová E, Rob L, Trnĕný M. [Burkitt lymphoma in pregnancy--case report]. Ceska Gynekol 2010; 75:248-251. [PMID: 20731306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
OBJECTIVE The aim of the study is to show the possible variations of early symptoms of haematological malignity during pregnancy and to summarize data about treatment modalities and possible management of gravidity in case of the disease. DESIGN Case report. SETTING Department of Obstetrics and gynaecology, Charles University, 2nd Medical Faculty; 1st internal clinic - department of hematology, Charles University, 1st Medical Faculty, Prague. METHODS Pubmed database was searched between years 1989 and 2009. The data we used focused on non- Hodgkin's lymphomas diagnosed during pregnancy, especially on Burkitt lymphoma. The treatment modalities, neonate outcomes and prognosis of the mothers were emphasised. CONCLUSION The diagnostics of haematological malignities in pregnancy is difficult. The most frequent symptoms are subfebris, fever of unknown etiology, lymphadenopathy, night sweats, infirmity and the weight lost. According to the literature the Burkitt lymphoma is potencialy currable disease during pregnancy. The close cooperation of the gynecologists and hematooncologists and the individualization of treatment based on the stage of pregnancy, localization of the tumorous mass and the agresivity of disease is needed.
Collapse
Affiliation(s)
- K Suchová
- Gynekologicko-porodnická klinika 2. LF UK a FN Motol, Praha.
| | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Robová H, Rob L, Pluta M, Halaska M, Chmel R. [Treatment of recurrent ovarian cancer]. Ceska Gynekol 2009; 74:464-468. [PMID: 21246797] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
OBJECTIVE The description of current treatment possibilities in recurrent ovarian cancer. DESIGN Review article. SETTING Obstetrics and Gynecology Department, Charles University 2nd Medical Faculty and University Hospital Motol, Prague. METHODS The review of literature on treatment of recurrent ovarian cancer. Current data on chemotherapy, surgery and targeted biological therapy in recurrent ovarian cancer. CONCLUSIONS Chemotherapy is indicated in most cases of recurrent ovarian cancer, surgery does not play an important role. Standard treatment of platinum-sensitive recurrent ovarian cancer is based on platinum combination chemotherapy. Standard treatment of platinum-refractory ovarian cancer represents non-platinum monotherapy. Targeted biological therapy should be still used only in the studies.
Collapse
Affiliation(s)
- H Robová
- Gynekologicko porodnická klinika 2. LF UK a FN Motol, Praha
| | | | | | | | | |
Collapse
|
32
|
Acero F, Aharonian F, Akhperjanian AG, Anton G, Barres de Almeida U, Bazer-Bachi AR, Becherini Y, Behera B, Bernlöhr K, Bochow A, Boisson C, Bolmont J, Borrel V, Brucker J, Brun F, Brun P, Bühler R, Bulik T, Büsching I, Boutelier T, Chadwick PM, Charbonnier A, Chaves RCG, Cheesebrough A, Chounet LM, Clapson AC, Coignet G, Dalton M, Daniel MK, Davids ID, Degrange B, Deil C, Dickinson HJ, Djannati-Ataï A, Domainko W, Drury LO, Dubois F, Dubus G, Dyks J, Dyrda M, Egberts K, Emmanoulopoulos D, Espigat P, Farnier C, Fegan S, Feinstein F, Fiasson A, Förster A, Fontaine G, Füßling M, Gabici S, Gallant YA, Gérard L, Gerbig D, Giebels B, Glicenstein JF, Glück B, Goret P, Göring D, Hauser D, Hauser M, Heinz S, Heinzelmann G, Henri G, Hermann G, Hinton JA, Hoffmann A, Hofmann W, Hofverberg P, Hoppe S, Horns D, Jacholkowska A, de Jager OC, Jahn C, Jung I, Katarzyński K, Katz U, Kaufmann S, Kerschhaggl M, Khangulyan D, Khélifi B, Keogh D, Klochkov D, Kluźniak W, Kneiske T, Komin N, Kosack K, Kossakowski R, Lamanna G, Lenain JP, Lohse T, Marandon V, Martineau-Huynh O, Marcowith A, Masbou J, Maurin D, McComb TJL, Medina MC, Méhault J, Moderski R, Moulin E, Naumann-Godo M, de Naurois M, Nedbal D, Nekrassov D, Nicholas B, Niemiec J, Nolan SJ, Ohm S, Olive JF, Wilhelmi EDO, Orford KJ, Ostrowski M, Panter M, Arribas MP, Pedaletti G, Pelletier G, Petrucci PO, Pita S, Pühlhofer G, Punch M, Quirrenbach A, Raubenheimer BC, Raue M, Rayner SM, Reimer O, Renaud M, Rieger F, Ripken J, Rob L, Rosier-Lees S, Rowell G, Rudak B, Rulten CB, Ruppel J, Sahakian V, Santangelo A, Schlickeiser R, Schöck FM, Schwanke U, Schwarzburg S, Schwemmer S, Shalchi A, Sikora M, Skilton JL, Sol H, Stawarz Ł, Steenkamp R, Stegmann C, Stinzing F, Superina G, Szostek A, Tam PH, Tavernet JP, Terrier R, Tibolla O, Tluczykont M, van Eldik C, Vasileiadis G, Venter C, Venter L, Vialle JP, Vincent P, Vivier M, Völk HJ, Volpe F, Wagner SJ, Ward M, Zdziarski AA, Zech A. Detection of Gamma Rays from a Starburst Galaxy. Science 2009; 326:1080-2. [DOI: 10.1126/science.1178826] [Citation(s) in RCA: 151] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Affiliation(s)
- F. Acero
- Laboratoire de Physique Théorique et Astroparticules, Université Montpellier 2, CNRS/IN2P3, CC 70, Place Eugène Bataillon, F-34095 Montpellier Cedex 5, France
| | - F. Aharonian
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
- Dublin Institute for Advanced Studies, 5 Merrion Square, Dublin 2, Ireland
| | - A. G. Akhperjanian
- Yerevan Physics Institute, 2 Alikhanian Brothers Street, 375036 Yerevan, Armenia
| | - G. Anton
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | | | - A. R. Bazer-Bachi
- Centre d’Etude Spatiale des Rayonnements, CNRS/UPS, 9 avenue du Colonel Roche, BP 4346, F-31029 Toulouse Cedex 4, France
| | - Y. Becherini
- Astroparticule et Cosmologie (APC), CNRS, Université Paris 7 Denis Diderot, 10, rue Alice Domon et Leonie Duquet, F-75205 Paris Cedex 13, France. UMR 7164 (CNRS, Université Paris VII, CEA, Observatoire de Paris)
| | - B. Behera
- Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
| | - K. Bernlöhr
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
- Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany
| | - A. Bochow
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - C. Boisson
- Laboratoire Univers et Théories, Observatoire de Paris, CNRS, Université Paris Diderot, 5 Place Jules Janssen, 92190 Meudon, France
| | - J. Bolmont
- Laboratoire de Physique Nucléaire et des Hautes Energies, Université Pierre et Marie Curie Paris 6, Université Denis Diderot Paris 7, CNRS/IN2P3, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - V. Borrel
- Centre d’Etude Spatiale des Rayonnements, CNRS/UPS, 9 avenue du Colonel Roche, BP 4346, F-31029 Toulouse Cedex 4, France
| | - J. Brucker
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - F. Brun
- Laboratoire de Physique Nucléaire et des Hautes Energies, Université Pierre et Marie Curie Paris 6, Université Denis Diderot Paris 7, CNRS/IN2P3, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - P. Brun
- Institut de Recherche sur les Lois Fondamentales de l’Univers/La Direction des Sciences de la Matière/Commissariat àl’Energie Atomique, CE Saclay, F-91191 Gif-sur-Yvette, Cedex, France
| | - R. Bühler
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - T. Bulik
- Astronomical Observatory, The University of Warsaw, Al. Ujazdowskie 4, 00-478 Warsaw, Poland
| | - I. Büsching
- Unit for Space Physics, North-West University, Potchefstroom 2520, South Africa
| | - T. Boutelier
- Laboratoire d’Astrophysique de Grenoble, Institut National des Sciences de l’Univers/CNRS, Université Joseph Fourier, BP 53, F-38041 Grenoble Cedex 9, France
| | - P. M. Chadwick
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, UK
| | - A. Charbonnier
- Laboratoire de Physique Nucléaire et des Hautes Energies, Université Pierre et Marie Curie Paris 6, Université Denis Diderot Paris 7, CNRS/IN2P3, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - R. C. G. Chaves
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - A. Cheesebrough
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, UK
| | - L.-M. Chounet
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | - A. C. Clapson
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - G. Coignet
- Laboratoire d’Annecy-le-Vieux de Physique des Particules, Université de Savoie, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - M. Dalton
- Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany
| | - M. K. Daniel
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, UK
| | - I. D. Davids
- Unit for Space Physics, North-West University, Potchefstroom 2520, South Africa
- University of Namibia, Private Bag 13301, Windhoek, Namibia
| | - B. Degrange
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | - C. Deil
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - H. J. Dickinson
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, UK
| | - A. Djannati-Ataï
- Astroparticule et Cosmologie (APC), CNRS, Université Paris 7 Denis Diderot, 10, rue Alice Domon et Leonie Duquet, F-75205 Paris Cedex 13, France. UMR 7164 (CNRS, Université Paris VII, CEA, Observatoire de Paris)
| | - W. Domainko
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - L. O’C. Drury
- Dublin Institute for Advanced Studies, 5 Merrion Square, Dublin 2, Ireland
| | - F. Dubois
- Laboratoire d’Annecy-le-Vieux de Physique des Particules, Université de Savoie, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - G. Dubus
- Laboratoire d’Astrophysique de Grenoble, Institut National des Sciences de l’Univers/CNRS, Université Joseph Fourier, BP 53, F-38041 Grenoble Cedex 9, France
| | - J. Dyks
- Nicolaus Copernicus Astronomical Center, ul. Bartycka 18, 00-716 Warsaw, Poland
| | - M. Dyrda
- Instytut Fizyki Jadrowej PAN, ul. Radzikowskiego 152, 31-342 Kraków, Poland
| | - K. Egberts
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - D. Emmanoulopoulos
- Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
| | - P. Espigat
- Astroparticule et Cosmologie (APC), CNRS, Université Paris 7 Denis Diderot, 10, rue Alice Domon et Leonie Duquet, F-75205 Paris Cedex 13, France. UMR 7164 (CNRS, Université Paris VII, CEA, Observatoire de Paris)
| | - C. Farnier
- Laboratoire de Physique Théorique et Astroparticules, Université Montpellier 2, CNRS/IN2P3, CC 70, Place Eugène Bataillon, F-34095 Montpellier Cedex 5, France
| | - S. Fegan
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | - F. Feinstein
- Laboratoire de Physique Théorique et Astroparticules, Université Montpellier 2, CNRS/IN2P3, CC 70, Place Eugène Bataillon, F-34095 Montpellier Cedex 5, France
| | - A. Fiasson
- Laboratoire d’Annecy-le-Vieux de Physique des Particules, Université de Savoie, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - A. Förster
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - G. Fontaine
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | - M. Füßling
- Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany
| | - S. Gabici
- Dublin Institute for Advanced Studies, 5 Merrion Square, Dublin 2, Ireland
| | - Y. A. Gallant
- Laboratoire de Physique Théorique et Astroparticules, Université Montpellier 2, CNRS/IN2P3, CC 70, Place Eugène Bataillon, F-34095 Montpellier Cedex 5, France
| | - L. Gérard
- Astroparticule et Cosmologie (APC), CNRS, Université Paris 7 Denis Diderot, 10, rue Alice Domon et Leonie Duquet, F-75205 Paris Cedex 13, France. UMR 7164 (CNRS, Université Paris VII, CEA, Observatoire de Paris)
| | - D. Gerbig
- Institut für Theoretische Physik, Lehrstuhl IV: Weltraum und Astrophysik, Ruhr-Universität Bochum, D 44780 Bochum, Germany
| | - B. Giebels
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | - J. F. Glicenstein
- Institut de Recherche sur les Lois Fondamentales de l’Univers/La Direction des Sciences de la Matière/Commissariat àl’Energie Atomique, CE Saclay, F-91191 Gif-sur-Yvette, Cedex, France
| | - B. Glück
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - P. Goret
- Institut de Recherche sur les Lois Fondamentales de l’Univers/La Direction des Sciences de la Matière/Commissariat àl’Energie Atomique, CE Saclay, F-91191 Gif-sur-Yvette, Cedex, France
| | - D. Göring
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - D. Hauser
- Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
| | - M. Hauser
- Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
| | - S. Heinz
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - G. Heinzelmann
- Universität Hamburg, Institut für Experimentalphysik, Luruper Chaussee 149, D 22761 Hamburg, Germany
| | - G. Henri
- Laboratoire d’Astrophysique de Grenoble, Institut National des Sciences de l’Univers/CNRS, Université Joseph Fourier, BP 53, F-38041 Grenoble Cedex 9, France
| | - G. Hermann
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - J. A. Hinton
- School of Physics and Astronomy, University of Leeds, Leeds LS2 9JT, UK
| | - A. Hoffmann
- Institut für Astronomie und Astrophysik, Universität Tübingen, Sand 1, D 72076 Tübingen, Germany
| | - W. Hofmann
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - P. Hofverberg
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - S. Hoppe
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - D. Horns
- Universität Hamburg, Institut für Experimentalphysik, Luruper Chaussee 149, D 22761 Hamburg, Germany
| | - A. Jacholkowska
- Laboratoire de Physique Nucléaire et des Hautes Energies, Université Pierre et Marie Curie Paris 6, Université Denis Diderot Paris 7, CNRS/IN2P3, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - O. C. de Jager
- Unit for Space Physics, North-West University, Potchefstroom 2520, South Africa
| | - C. Jahn
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - I. Jung
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - K. Katarzyński
- Toruń Centre for Astronomy, Nicolaus Copernicus University, ul. Gagarina 11, 87-100 Toruń, Poland
| | - U. Katz
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - S. Kaufmann
- Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
| | - M. Kerschhaggl
- Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany
| | - D. Khangulyan
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - B. Khélifi
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | - D. Keogh
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, UK
| | - D. Klochkov
- Institut für Astronomie und Astrophysik, Universität Tübingen, Sand 1, D 72076 Tübingen, Germany
| | - W. Kluźniak
- Nicolaus Copernicus Astronomical Center, ul. Bartycka 18, 00-716 Warsaw, Poland
| | - T. Kneiske
- Universität Hamburg, Institut für Experimentalphysik, Luruper Chaussee 149, D 22761 Hamburg, Germany
| | - Nu. Komin
- Institut de Recherche sur les Lois Fondamentales de l’Univers/La Direction des Sciences de la Matière/Commissariat àl’Energie Atomique, CE Saclay, F-91191 Gif-sur-Yvette, Cedex, France
| | - K. Kosack
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - R. Kossakowski
- Laboratoire d’Annecy-le-Vieux de Physique des Particules, Université de Savoie, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - G. Lamanna
- Laboratoire d’Annecy-le-Vieux de Physique des Particules, Université de Savoie, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - J.-P. Lenain
- Laboratoire Univers et Théories, Observatoire de Paris, CNRS, Université Paris Diderot, 5 Place Jules Janssen, 92190 Meudon, France
| | - T. Lohse
- Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany
| | - V. Marandon
- Astroparticule et Cosmologie (APC), CNRS, Université Paris 7 Denis Diderot, 10, rue Alice Domon et Leonie Duquet, F-75205 Paris Cedex 13, France. UMR 7164 (CNRS, Université Paris VII, CEA, Observatoire de Paris)
| | - O. Martineau-Huynh
- Laboratoire de Physique Nucléaire et des Hautes Energies, Université Pierre et Marie Curie Paris 6, Université Denis Diderot Paris 7, CNRS/IN2P3, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - A. Marcowith
- Laboratoire de Physique Théorique et Astroparticules, Université Montpellier 2, CNRS/IN2P3, CC 70, Place Eugène Bataillon, F-34095 Montpellier Cedex 5, France
| | - J. Masbou
- Laboratoire d’Annecy-le-Vieux de Physique des Particules, Université de Savoie, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - D. Maurin
- Laboratoire de Physique Nucléaire et des Hautes Energies, Université Pierre et Marie Curie Paris 6, Université Denis Diderot Paris 7, CNRS/IN2P3, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - T. J. L. McComb
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, UK
| | - M. C. Medina
- Laboratoire Univers et Théories, Observatoire de Paris, CNRS, Université Paris Diderot, 5 Place Jules Janssen, 92190 Meudon, France
| | - J. Méhault
- Laboratoire de Physique Théorique et Astroparticules, Université Montpellier 2, CNRS/IN2P3, CC 70, Place Eugène Bataillon, F-34095 Montpellier Cedex 5, France
| | - R. Moderski
- Nicolaus Copernicus Astronomical Center, ul. Bartycka 18, 00-716 Warsaw, Poland
| | - E. Moulin
- Laboratoire Univers et Théories, Observatoire de Paris, CNRS, Université Paris Diderot, 5 Place Jules Janssen, 92190 Meudon, France
| | - M. Naumann-Godo
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | - M. de Naurois
- Laboratoire de Physique Nucléaire et des Hautes Energies, Université Pierre et Marie Curie Paris 6, Université Denis Diderot Paris 7, CNRS/IN2P3, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - D. Nedbal
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, V Holesovickách 2, 180 00, Prague, Czech Republic
| | - D. Nekrassov
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - B. Nicholas
- School of Chemistry and Physics, University of Adelaide, Adelaide 5005, Australia
| | - J. Niemiec
- Instytut Fizyki Jadrowej PAN, ul. Radzikowskiego 152, 31-342 Kraków, Poland
| | - S. J. Nolan
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, UK
| | - S. Ohm
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - J-F. Olive
- Centre d’Etude Spatiale des Rayonnements, CNRS/UPS, 9 avenue du Colonel Roche, BP 4346, F-31029 Toulouse Cedex 4, France
| | - E. de Oña Wilhelmi
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - K. J. Orford
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, UK
| | - M. Ostrowski
- Obserwatorium Astronomiczne, Uniwersytet Jagielloński, ul. Orla 171, 30-244 Kraków, Poland
| | - M. Panter
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - M. Paz Arribas
- Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany
| | - G. Pedaletti
- Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
| | - G. Pelletier
- Laboratoire d’Astrophysique de Grenoble, Institut National des Sciences de l’Univers/CNRS, Université Joseph Fourier, BP 53, F-38041 Grenoble Cedex 9, France
| | - P.-O. Petrucci
- Laboratoire d’Astrophysique de Grenoble, Institut National des Sciences de l’Univers/CNRS, Université Joseph Fourier, BP 53, F-38041 Grenoble Cedex 9, France
| | - S. Pita
- Astroparticule et Cosmologie (APC), CNRS, Université Paris 7 Denis Diderot, 10, rue Alice Domon et Leonie Duquet, F-75205 Paris Cedex 13, France. UMR 7164 (CNRS, Université Paris VII, CEA, Observatoire de Paris)
| | - G. Pühlhofer
- Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
- Institut für Astronomie und Astrophysik, Universität Tübingen, Sand 1, D 72076 Tübingen, Germany
| | - M. Punch
- Astroparticule et Cosmologie (APC), CNRS, Université Paris 7 Denis Diderot, 10, rue Alice Domon et Leonie Duquet, F-75205 Paris Cedex 13, France. UMR 7164 (CNRS, Université Paris VII, CEA, Observatoire de Paris)
| | - A. Quirrenbach
- Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
| | - B. C. Raubenheimer
- Unit for Space Physics, North-West University, Potchefstroom 2520, South Africa
| | - M. Raue
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
- European Associated Laboratory for Gamma-Ray Astronomy, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - S. M. Rayner
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, UK
| | - O. Reimer
- Institut für Astro und Teilchenphysik, Leopold-Franzens-Universität Innsbruck, A6020 Innsbruck, Austria
- KIPAC Kavli Institute for Particle Physics and Cosmology, Stanford University, Stanford, CA 94305, USA
| | - M. Renaud
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
- Astroparticule et Cosmologie (APC), CNRS, Université Paris 7 Denis Diderot, 10, rue Alice Domon et Leonie Duquet, F-75205 Paris Cedex 13, France. UMR 7164 (CNRS, Université Paris VII, CEA, Observatoire de Paris)
| | - F. Rieger
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
- European Associated Laboratory for Gamma-Ray Astronomy, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - J. Ripken
- Universität Hamburg, Institut für Experimentalphysik, Luruper Chaussee 149, D 22761 Hamburg, Germany
| | - L. Rob
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, V Holesovickách 2, 180 00, Prague, Czech Republic
| | - S. Rosier-Lees
- Laboratoire d’Annecy-le-Vieux de Physique des Particules, Université de Savoie, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - G. Rowell
- School of Chemistry and Physics, University of Adelaide, Adelaide 5005, Australia
| | - B. Rudak
- Nicolaus Copernicus Astronomical Center, ul. Bartycka 18, 00-716 Warsaw, Poland
| | - C. B. Rulten
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, UK
| | - J. Ruppel
- Institut für Theoretische Physik, Lehrstuhl IV: Weltraum und Astrophysik, Ruhr-Universität Bochum, D 44780 Bochum, Germany
| | - V. Sahakian
- Yerevan Physics Institute, 2 Alikhanian Brothers Street, 375036 Yerevan, Armenia
| | - A. Santangelo
- Institut für Astronomie und Astrophysik, Universität Tübingen, Sand 1, D 72076 Tübingen, Germany
| | - R. Schlickeiser
- Institut für Theoretische Physik, Lehrstuhl IV: Weltraum und Astrophysik, Ruhr-Universität Bochum, D 44780 Bochum, Germany
| | - F. M. Schöck
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - U. Schwanke
- Institut für Physik, Humboldt-Universität zu Berlin, Newtonstrasse 15, D 12489 Berlin, Germany
| | - S. Schwarzburg
- Institut für Astronomie und Astrophysik, Universität Tübingen, Sand 1, D 72076 Tübingen, Germany
| | - S. Schwemmer
- Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
| | - A. Shalchi
- Institut für Theoretische Physik, Lehrstuhl IV: Weltraum und Astrophysik, Ruhr-Universität Bochum, D 44780 Bochum, Germany
| | - M. Sikora
- Nicolaus Copernicus Astronomical Center, ul. Bartycka 18, 00-716 Warsaw, Poland
| | - J. L. Skilton
- School of Physics and Astronomy, University of Leeds, Leeds LS2 9JT, UK
| | - H. Sol
- Laboratoire Univers et Théories, Observatoire de Paris, CNRS, Université Paris Diderot, 5 Place Jules Janssen, 92190 Meudon, France
| | - Ł. Stawarz
- Obserwatorium Astronomiczne, Uniwersytet Jagielloński, ul. Orla 171, 30-244 Kraków, Poland
| | - R. Steenkamp
- University of Namibia, Private Bag 13301, Windhoek, Namibia
| | - C. Stegmann
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - F. Stinzing
- Universität Erlangen-Nürnberg, Physikalisches Institut, Erwin-Rommel-Strasse 1, D 91058 Erlangen, Germany
| | - G. Superina
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | - A. Szostek
- Laboratoire d’Astrophysique de Grenoble, Institut National des Sciences de l’Univers/CNRS, Université Joseph Fourier, BP 53, F-38041 Grenoble Cedex 9, France
- Obserwatorium Astronomiczne, Uniwersytet Jagielloński, ul. Orla 171, 30-244 Kraków, Poland
| | - P. H. Tam
- Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
| | - J.-P. Tavernet
- Laboratoire de Physique Nucléaire et des Hautes Energies, Université Pierre et Marie Curie Paris 6, Université Denis Diderot Paris 7, CNRS/IN2P3, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - R. Terrier
- Astroparticule et Cosmologie (APC), CNRS, Université Paris 7 Denis Diderot, 10, rue Alice Domon et Leonie Duquet, F-75205 Paris Cedex 13, France. UMR 7164 (CNRS, Université Paris VII, CEA, Observatoire de Paris)
| | - O. Tibolla
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - M. Tluczykont
- Universität Hamburg, Institut für Experimentalphysik, Luruper Chaussee 149, D 22761 Hamburg, Germany
| | - C. van Eldik
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - G. Vasileiadis
- Laboratoire de Physique Théorique et Astroparticules, Université Montpellier 2, CNRS/IN2P3, CC 70, Place Eugène Bataillon, F-34095 Montpellier Cedex 5, France
| | - C. Venter
- Unit for Space Physics, North-West University, Potchefstroom 2520, South Africa
| | - L. Venter
- Laboratoire Univers et Théories, Observatoire de Paris, CNRS, Université Paris Diderot, 5 Place Jules Janssen, 92190 Meudon, France
| | - J. P. Vialle
- Laboratoire d’Annecy-le-Vieux de Physique des Particules, Université de Savoie, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - P. Vincent
- Laboratoire de Physique Nucléaire et des Hautes Energies, Université Pierre et Marie Curie Paris 6, Université Denis Diderot Paris 7, CNRS/IN2P3, 4 Place Jussieu, F-75252, Paris Cedex 5, France
| | - M. Vivier
- Institut de Recherche sur les Lois Fondamentales de l’Univers/La Direction des Sciences de la Matière/Commissariat àl’Energie Atomique, CE Saclay, F-91191 Gif-sur-Yvette, Cedex, France
| | - H. J. Völk
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - F. Volpe
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | - S. J. Wagner
- Landessternwarte, Universität Heidelberg, Königstuhl, D 69117 Heidelberg, Germany
| | - M. Ward
- University of Durham, Department of Physics, South Road, Durham DH1 3LE, UK
| | - A. A. Zdziarski
- Nicolaus Copernicus Astronomical Center, ul. Bartycka 18, 00-716 Warsaw, Poland
| | - A. Zech
- Laboratoire Univers et Théories, Observatoire de Paris, CNRS, Université Paris Diderot, 5 Place Jules Janssen, 92190 Meudon, France
| |
Collapse
|
33
|
Lambrexhe M, Frederick B, Burie D, Cavuto C, Rob L, Rasquin I, Coiffier N, Untereiner M. Prévention primaire et secondaire des complications aiguës de la radiothérapie des cancers de la tête et du cou. Cancer Radiother 2009. [DOI: 10.1016/j.canrad.2009.08.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
34
|
Untereiner M, Frederick B, Burie D, Cavuto C, Rob L, Coiffier N, Colet M. Radiothérapie mammaire et gestion des risques-patients avec évaluation continue d’indicateurs cliniques. Cancer Radiother 2009. [DOI: 10.1016/j.canrad.2009.08.121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
35
|
Halaska MJ, Suchová K, Spálová I, Robová H, Stankusová H, Pluta M, Rob L. [Chemotherapy during pregnancy]. Ceska Gynekol 2009; 74:252-256. [PMID: 20564977] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
OBJECTIVE The aim of the study is to summarize current data on chemotherapy administered during pregnancy. TYPE OF STUDY Review article. SETTING Dept. of Obstetrics and Gynaecology of the Charles University in Prague, 2nd Medical Faculty, University Hospital. SUBJECT AND METHOD Pubmed database was searched between the years 1980 and 2009 with the combinations of key words concerning cytostatics, therapy and pregnancy. Cisplatin administration was identified in 38 cases. Eight cases of administration of carboplatin during pregnancy were found with normal neonatal outcome Twenty-one case reports were found on the use of taxanes during pregnancy: 14 on paclitaxel and 7 on docetaxel. CONCLUSION Based on the literature the administration of cytostatics during pregnancy can be considered under a close supervision and long-term follow-up in dedicated teams.
Collapse
|
36
|
Acciari VA, Aliu E, Arlen T, Bautista M, Beilicke M, Benbow W, Bradbury SM, Buckley JH, Bugaev V, Butt Y, Byrum K, Cannon A, Celik O, Cesarini A, Chow YC, Ciupik L, Cogan P, Cui W, Dickherber R, Fegan SJ, Finley JP, Fortin P, Fortson L, Furniss A, Gall D, Gillanders GH, Grube J, Guenette R, Gyuk G, Hanna D, Holder J, Horan D, Hui CM, Humensky TB, Imran A, Kaaret P, Karlsson N, Kieda D, Kildea J, Konopelko A, Krawczynski H, Krennrich F, Lang MJ, LeBohec S, Maier G, McCann A, McCutcheon M, Millis J, Moriarty P, Ong RA, Otte AN, Pandel D, Perkins JS, Petry D, Pohl M, Quinn J, Ragan K, Reyes LC, Reynolds PT, Roache E, Roache E, Rose HJ, Schroedter M, Sembroski GH, Smith AW, Swordy SP, Theiling M, Toner JA, Varlotta A, Vincent S, Wakely SP, Ward JE, Weekes TC, Weinstein A, Williams DA, Wissel S, Wood M, Walker RC, Davies F, Hardee PE, Junor W, Ly C, Aharonian F, Akhperjanian AG, Anton G, Barres de Almeida U, Bazer-Bachi AR, Becherini Y, Behera B, Bernlöhr K, Bochow A, Boisson C, Bolmont J, Borrel V, Brucker J, Brun F, Brun P, Bühler R, Bulik T, Büsching I, Boutelier T, Chadwick PM, Charbonnier A, Chaves RCG, Cheesebrough A, Chounet LM, Clapson AC, Coignet G, Dalton M, Daniel MK, Davids ID, Degrange B, Deil C, Dickinson HJ, Djannati-Ataï A, Domainko W, Drury LO, Dubois F, Dubus G, Dyks J, Dyrda M, Egberts K, Emmanoulopoulos D, Espigat P, Farnier C, Feinstein F, Fiasson A, Förster A, Fontaine G, Füssling M, Gabici S, Gallant YA, Gérard L, Gerbig D, Giebels B, Glicenstein JF, Glück B, Goret P, Göhring D, Hauser D, Hauser M, Heinz S, Heinzelmann G, Henri G, Hermann G, Hinton JA, Hoffmann A, Hofmann W, Holleran M, Hoppe S, Horns D, Jacholkowska A, de Jager OC, Jahn C, Jung I, Katarzyński K, Katz U, Kaufmann S, Kendziorra E, Kerschhaggl M, Khangulyan D, Khélifi B, Keogh D, Kluźniak W, Kneiske T, Komin N, Kosack K, Lamanna G, Lenain JP, Lohse T, Marandon V, Martin JM, Martineau-Huynh O, Marcowith A, Maurin D, McComb TJL, Medina MC, Moderski R, Moulin E, Naumann-Godo M, de Naurois M, Nedbal D, Nekrassov D, Nicholas B, Niemiec J, Nolan SJ, Ohm S, Olive JF, de Oña Wilhelmi E, Orford KJ, Ostrowski M, Panter M, Paz Arribas M, Pedaletti G, Pelletier G, Petrucci PO, Pita S, Pühlhofer G, Punch M, Quirrenbach A, Raubenheimer BC, Raue M, Rayner SM, Renaud M, Rieger F, Ripken J, Rob L, Rosier-Lees S, Rowell G, Rudak B, Rulten CB, Ruppel J, Sahakian V, Santangelo A, Schlickeiser R, Schöck FM, Schröder R, Schwanke U, Schwarzburg S, Schwemmer S, Shalchi A, Sikora M, Skilton JL, Sol H, Spangler D, Stawarz Ł, Steenkamp R, Stegmann C, Stinzing F, Superina G, Szostek A, Tam PH, Tavernet JP, Terrier R, Tibolla O, Tluczykont M, van Eldik C, Vasileiadis G, Venter C, Venter L, Vialle JP, Vincent P, Vivier M, Völk HJ, Volpe F, Wagner SJ, Ward M, Zdziarski AA, Zech A, Anderhub H, Antonelli LA, Antoranz P, Backes M, Baixeras C, Balestra S, Barrio JA, Bastieri D, Becerra González J, Becker JK, Bednarek W, Berger K, Bernardini E, Biland A, Bock RK, Bonnoli G, Bordas P, Borla Tridon D, Bosch-Ramon V, Bose D, Braun I, Bretz T, Britvitch I, Camara M, Carmona E, Commichau S, Contreras JL, Cortina J, Costado MT, Covino S, Curtef V, Dazzi F, De Angelis A, De Cea del Pozo E, Delgado Mendez C, De los Reyes R, De Lotto B, De Maria M, De Sabata F, Dominguez A, Dorner D, Doro M, Elsaesser D, Errando M, Ferenc D, Fernández E, Firpo R, Fonseca MV, Font L, Galante N, García López RJ, Garczarczyk M, Gaug M, Goebel F, Hadasch D, Hayashida M, Herrero A, Hildebrand D, Höhne-Mönch D, Hose J, Hsu CC, Jogler T, Kranich D, La Barbera A, Laille A, Leonardo E, Lindfors E, Lombardi S, Longo F, López M, Lorenz E, Majumdar P, Maneva G, Mankuzhiyil N, Mannheim K, Maraschi L, Mariotti M, Martínez M, Mazin D, Meucci M, Miranda JM, Mirzoyan R, Miyamoto H, Moldón J, Moles M, Moralejo A, Nieto D, Nilsson K, Ninkovic J, Oya I, Paoletti R, Paredes JM, Pasanen M, Pascoli D, Pauss F, Pegna RG, Perez-Torres MA, Persic M, Peruzzo L, Prada F, Prandini E, Puchades N, Reichardt I, Rhode W, Ribó M, Rico J, Rissi M, Robert A, Rügamer S, Saggion A, Saito TY, Salvati M, Sanchez-Conde M, Satalecka K, Scalzotto V, Scapin V, Schweizer T, Shayduk M, Shore SN, Sidro N, Sierpowska-Bartosik A, Sillanpää A, Sitarek J, Sobczynska D, Spanier F, Stamerra A, Stark LS, Takalo L, Tavecchio F, Temnikov P, Tescaro D, Teshima M, Torres DF, Turini N, Vankov H, Wagner RM, Zabalza V, Zandanel F, Zanin R, Zapatero J. Radio Imaging of the Very-High-Energy γ-Ray Emission Region in the Central Engine of a Radio Galaxy. Science 2009; 325:444-8. [PMID: 19574351 DOI: 10.1126/science.1175406] [Citation(s) in RCA: 157] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
37
|
Feldmár P, Hrehorcák M, Korbel' M, Malá I, Suchová K, Halaska M, Chmel R, Rob L. [Bioimpedance analysis--a new method in prediction and early detection of ovarian hyperstimulation syndrome?]. Ceska Gynekol 2009; 74:8-12. [PMID: 19408848] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
OBJECTIVE The aim of the study was to establish a new method of the multiple-frequency bioimpedance analysis (MFBIA) for patients with controlled ovarian hyperstimulation (COH) and to determine the significance of this method in prediction and early diagnosis of severe forms of ovarian hyperstimulation syndrome (OHSS). DESIGN Prospective case control study. SETTING Department of Obstetrics and Gynecology, 2nd Medical Faculty, Charles University and University Hospital Motol, Prague. METHODS 53 patients were recruited into the case control study. The surface body impedances for the frequencies of the current 1, 5, 50 and 100 kHz were measured. Study group included 13 patients with developed OHSS grade III.-V. according Golans classification. The control group included 40 women undergoing COH without developed OHSS. Measurements of impedances were performed by MFBIA device. RESULTS The decrease of the values of impedance between the day of oocyte retrieval and the day of embryotransfer significantly increases relative risk of OHSS grade III.-V. development. The best correlation was found for the frequency of 5 kHz (9.08 p<0.0001). The study suggests, the predictive value of MFBIA in OHSS development might be higher than the number of retrieved oocytes (>20 oocytes-RR 5,71). CONCLUSION Patients in risk of OHSS development are those with decreasing impedances. The highest predictive value of OHSS development is for the impedances at frequency of 5 kHz. Greater multicenter studies should be done to confirm our preliminary results.
Collapse
Affiliation(s)
- P Feldmár
- Gynekologicko-porodnická klinika 2. LF UK a FN Motol, Praha.
| | | | | | | | | | | | | | | |
Collapse
|
38
|
Aharonian F, Akhperjanian AG, Barres de Almeida U, Bazer-Bachi AR, Becherini Y, Behera B, Benbow W, Bernlöhr K, Boisson C, Bochow A, Borrel V, Braun I, Brion E, Brucker J, Brun P, Brucker R, Bulik T, Büsching I, Boutelier T, Carrigan S, Chadwick PM, Charbonnier A, Chaves RCG, Cheesebrough A, Chounet LM, Clapson AC, Coignet G, Costamante L, Dalton M, Degrange B, Deil C, Dickinson HJ, Djannati-Ataï A, Domainko W, Drury LO, Dubois F, Dubus G, Dyks J, Dyrda M, Egberts K, Emmanoulopoulos D, Espigat P, Farnier C, Feinstein F, Fiasson A, Fontaine G, Füsling M, Gabici S, Gallant YA, Gérard L, Giebels B, Glicenstein JF, Glück B, Goret P, Hadjichristidis C, Hauser D, Hauser M, Heinz S, Heinzelmann G, Henri G, Hermann G, Hinton JA, Hoffmann A, Hofmann W, Holleran M, Hoppe S, Horns D, Jacholkowska A, de Jager OC, Jung I, Katarzyński K, Kaufmann S, Kendziorra E, Kerschhaggl M, Khangulyan D, Khélifi B, Keogh D, Komin N, Kosack K, Lamanna G, Lenain JP, Lohse T, Marandon V, Martin JM, Martineau-Huynh O, Marcowith A, Maurin D, McComb TJL, Medina C, Moderski R, Moulin E, Naumann-Godo M, de Naurois M, Nedbal D, Nekrassov D, Niemiec J, Nolan SJ, Ohm S, Olive JF, de Oña Wilhelmi E, Orford KJ, Osborne JL, Ostrowski M, Panter M, Pedaletti G, Pelletier G, Petrucci PO, Pita S, Pühlhofer G, Punch M, Quirrenbach A, Raubenheimer BC, Raue M, Rayner SM, Renaud M, Rieger F, Ripken J, Rob L, Rosier-Lees S, Rowell G, Rudak B, Rulten CB, Ruppel J, Sahakian V, Santangelo A, Schlickeiser R, Schöck FM, Schröder R, Schwanke U, Schwarzburg S, Schwemmer S, Shalchi A, Skilton JL, Sol H, Spangler D, Stawarz Ł, Steenkamp R, Stegmann C, Superina G, Tam PH, Tavernet JP, Terrier R, Tibolla O, van Eldik C, Vasileiadis G, Venter C, Vialle JP, Vincent P, Vivier M, Völk HJ, Volpe F, Wagner SJ, Ward M, Zdziarski AA, Zech A. Energy spectrum of cosmic-ray electrons at TeV energies. Phys Rev Lett 2008; 101:261104. [PMID: 19437632 DOI: 10.1103/physrevlett.101.261104] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
The very large collection area of ground-based gamma-ray telescopes gives them a substantial advantage over balloon or satellite based instruments in the detection of very-high-energy (>600 GeV) cosmic-ray electrons. Here we present the electron spectrum derived from data taken with the High Energy Stereoscopic System (H.E.S.S.) of imaging atmospheric Cherenkov telescopes. In this measurement, the first of this type, we are able to extend the measurement of the electron spectrum beyond the range accessible to direct measurements. We find evidence for a substantial steepening in the energy spectrum above 600 GeV compared to lower energies.
Collapse
Affiliation(s)
- F Aharonian
- Max-Planck-Institut für Kernphysik, P.O. Box 103980, D 69029 Heidelberg, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Strnad P, Rob L, Skapa P, Stankusová H, Michalová K, Chod J. [The clinical significance of sentinel lymph node micrometastases in breast cancer]. Ceska Gynekol 2008; 73:360-364. [PMID: 19170371] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
OBJECTIVE The advent of sentinel lymph node biopsy and improvements in histopathological and immunohistochemical analysis has increased the rate at which micrometastases are identified. However their significance has been the subject of much debate. Published studies have reported divergent results regarding the significance and implications of axillary lymph node micrometastases. Some studies demonstrate no associations, whilst others have found these to be indicators of poor prognosis, associated with non-SLN involvement, in addition to local and distant failure. The objective of our study was to evaluate the impact of sentinel lymph node micrometastatic cancer to prognosis of the disease. DESIGN Retrospective study. SETTING Departments of Gynecology and Obstetrics, Faculty Hospital, Prague. METHODS From January 2000 to December 2006 in 87 cases with sentinel axillary node negative cancer we reexamined the axillary tissue blocks by serial sectioning, haematoxilin-eosin staining and immunohistochemistry. Additional 15 cases of micrometastatic sentinel node involvement detected by frozen section were included. The overall and disease free survivals of patients with sentinel negative status (N0-67 cases) and with sentinel node micrometastases (Nmic-35 cases) were evaluated. The median follow-up was 60 months (24-96 months). RESULTS Micrometastases (Nmic) were found in 20 cases (23%). From the group of 67 nodes negative patients (N0) in 7 cases (10.5%) developed tumor recurrence and from the group of 35 Nmic in 5 cases developed five tumor recurrences (13.3%). In the group of N0 patients developed 2 regional recurrences and 3 patients died, but 2 patients died of other causes. In the group of Nmic developed one regional recurrence and 3 patients died of generalization of disease. CONCLUSION Our study demonstrated that the presence of sentinel node micrometastases is associated with risk of development of distant metastases and generalization of the disease, but not with higher risk of regional recurrence.
Collapse
Affiliation(s)
- P Strnad
- Gynekologicko-porodnická klinika 2. LF UK a FN Motol, Praha
| | | | | | | | | | | |
Collapse
|
40
|
Aharonian F, Akhperjanian AG, Barres de Almeida U, Bazer-Bachi AR, Becherini Y, Behera B, Beilicke M, Benbow W, Bernlöhr K, Boisson C, Bochow A, Borrel V, Braun I, Brion E, Brucker J, Brun P, Bühler R, Bulik T, Büsching I, Boutelier T, Carrigan S, Chadwick PM, Charbonnier A, Chaves RCG, Chounet LM, Clapson AC, Coignet G, Costamante L, Dalton M, Degrange B, Deil C, Dickinson HJ, Djannati-Ataï A, Domainko W, Drury LO, Dubois F, Dubus G, Dyks J, Egberts K, Emmanoulopoulos D, Espigat P, Farnier C, Feinstein F, Fiasson A, Förster A, Fontaine G, Füssling M, Gabici S, Gallant YA, Gérard L, Giebels B, Glicenstein JF, Glück B, Goret P, Hadjichristidis C, Hauser D, Hauser M, Heinz S, Heinzelmann G, Henri G, Hermann G, Hinton JA, Hoffmann A, Hofmann W, Holleran M, Hoppe S, Horns D, Jacholkowska A, de Jager OC, Jung I, Katarzyński K, Kaufmann S, Kendziorra E, Kerschhaggl M, Khangulyan D, Khélifi B, Keogh D, Komin N, Kosack K, Lamanna G, Lenain JP, Lohse T, Marandon V, Martin JM, Martineau-Huynh O, Marcowith A, Maurin D, McComb TJL, Medina C, Moderski R, Moulin E, Naumann-Godo M, de Naurois M, Nedbal D, Nekrassov D, Niemiec J, Nolan SJ, Ohm S, Olive JF, de Oña Wilhelmi E, Orford KJ, Osborne JL, Ostrowski M, Panter M, Pedaletti G, Pelletier G, Petrucci PO, Pita S, Pühlhofer G, Punch M, Quirrenbach A, Raubenheimer BC, Raue M, Rayner SM, Renaud M, Rieger F, Ripken J, Rob L, Rosier-Lees S, Rowell G, Rudak B, Ruppel J, Sahakian V, Santangelo A, Schlickeiser R, Schöck FM, Schröder R, Schwanke U, Schwarzburg S, Schwemmer S, Shalchi A, Skilton JL, Sol H, Spangler D, Stawarz Ł, Steenkamp R, Stegmann C, Superina G, Tam PH, Tavernet JP, Terrier R, Tibolla O, van Eldik C, Vasileiadis G, Venter C, Vialle JP, Vincent P, Vivier M, Völk HJ, Volpe F, Wagner SJ, Ward M, Zdziarski AA, Zech A. Limits on an energy dependence of the speed of light from a flare of the active galaxy PKS 2155-304. Phys Rev Lett 2008; 101:170402. [PMID: 18999724 DOI: 10.1103/physrevlett.101.170402] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/10/2008] [Indexed: 05/27/2023]
Abstract
In the past few decades, several models have predicted an energy dependence of the speed of light in the context of quantum gravity. For cosmological sources such as active galaxies, this minuscule effect can add up to measurable photon-energy dependent time lags. In this Letter a search for such time lags during the High Energy Stereoscopic System observations of the exceptional very high energy flare of the active galaxy PKS 2155-304 on 28 July 2006 is presented. Since no significant time lag is found, lower limits on the energy scale of speed of light modifications are derived.
Collapse
Affiliation(s)
- F Aharonian
- Max-Planck-Institut für Kernphysik, Heidelberg, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Hrehorcak M, Feldmar P, Halaska M, Vlk R, Rob L. Does body impedance correlate with body fluid redistribution in patients with developing OHSS? Fertil Steril 2008. [DOI: 10.1016/j.fertnstert.2008.07.910] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
42
|
Robova H, Pluta M, Hrehorcak M, Skapa P, Rob L. High-dose density chemotherapy followed by simple trachelectomy: full-term pregnancy. Int J Gynecol Cancer 2008; 18:1367-71. [PMID: 18217969 DOI: 10.1111/j.1525-1438.2007.01178.x] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
We report five patients with early-stage cervical cancer who do not fulfill criteria of fertility-sparing surgery (tumor more than 2 cm in the biggest diameter or infiltrating more than half of stroma). Five patients received three cycles of dose density neoadjuvant chemotherapy (NAC) at a 10-day interval: cisplatin plus ifosfamide in squamous cell cancer or plus doxorubicin in adenocarcinoma with good tolerance. After NAC, they underwent laparoscopic pelvic lymphadenectomy and vaginal simple trachelectomy. Two patients had no residual tumor, two had only microscopic residual disease, and one had macroscopic residual disease. Two women became pregnant 5 and 8 months after surgery, one delivered in term healthy baby and one is now in the second trimester of pregnancy without any complications. NAC followed by fertility-sparing surgery seems to be feasible treatment for women with tumor bigger than 2 cm or infiltrated more than half of the stroma.
Collapse
Affiliation(s)
- H Robova
- Department of Obstetrics and Gynecology, University Hospital Motol, 2nd Medical Faculty, Charles University, Prague, Czech Republic
| | | | | | | | | |
Collapse
|
43
|
Chmel R, Novácková M, Horcicka L, Pastor Z, Rob L. [Abdominal sacrocolpopexy--simple and still actual method in the treatment of vaginal vault prolapse?]. Ceska Gynekol 2008; 73:47-53. [PMID: 18411642] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
OBJECTIVE To evaluate the effectiveness and complications of abdominal sacrocolpopexy in the treatment of vaginal vault prolapse. DESIGN Review article. SETTING Obstetrics and Gynecology Department, Charles University 2nd Medical Faculty and Teaching Hospital Motol, Prague. METHODS Review from biomedical database Medline from 1960 till 2006. The articles were found under the key words: vaginal vault prolaps, abdominal sacrocolpopexy, effectiveness, complications, urinary incontinence, female sexual dysfunctions. RESULTS The effectiveness of surgery is getting near to 100 percent in the smaller groups between 11 and 21 women. The larger groups are presenting greater success rate variability from 85 to 97 percent. The studies with up to 2 years of follow up are giving representative results of the effectiveness of surgery. Prolapse recurrence and cystocele, rectocele, enterocele and stress urinary incontinence occurrance belong among the characteristic failure signs. Studies evaluating abdominal sacrocolpopexy argue low incidence of complications. Complications connected with surgery can be divided to intraoperative and early and late postoperative. Bleeding from injured medial sacral artery, cystotomy, enterotomy and ureterotomy are the most common intraoperative complications. Wound infection, ileus and urinary tract infection are the most often early postoperative complications. Stress urinary incontinence, anterior or posterior vaginal wall descent, recurrence of vaginal vault prolapse and mesh erosion through vaginal wall are characteristic late postoperative complications. CONCLUSIONS Abdominal sacrocolpopexy can be a method of choice in the treatment of vaginal vault prolapse, mainly because of the low morbidity and high success rate. Polypropylene mesh is the prefered suspension structure but the accurate surgical technique is the most important for the abdominal sacrocolpopexy success and safety.
Collapse
Affiliation(s)
- R Chmel
- Gynekologicko-porodnická klinika 2. LF UK a FN Motol, Praha.
| | | | | | | | | |
Collapse
|
44
|
Chod J, Zavadova E, Halaska MJ, Strnad P, Fucikova T, Rob L. Preoperative transforming growth factor-beta 1 (TGF-beta 1) plasma levels in operable breast cancer patients. EUR J GYNAECOL ONCOL 2008; 29:613-616. [PMID: 19115689] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
OBJECTIVES The aim of this project was to search for new risk prognostic markers in the early stage of breast cancer. We tested preoperative plasma transforming growth factor - beta 1 (TGF- beta 1) levels in patients with operable breast cancer. Correlation with traditional prognostic markers and with positivity/negativity sentinel lymph node was evaluated. MATERIALS AND METHODS Between 2003 and 2005, 36 patients with operable breast cancer (T1-2, N0-1, M0) with positive or negative sentinel lymph nodes were evaluated for their plasma TGF-beta 1. Twenty-seven healthy individuals (9 premenopausal and 18 postmenopausal) served as controls. Patients were evaluated for the traditional prognostic markers including tumor characteristics, positivity and negativity of sentinel lymph node, TNM, tumor grade, expression of tumor markers CA 15-3 and CEA, hormonal status (pre- or postmenopausal patients, estrogen and progesteron receptor expression), ERB and p53 expression. Predictive value of TGF-beta 1 level and correlation with either of the assessed parameters was tested by one way ANOVA analysis. RESULTS Measurements of preoperative plasma TGF-beta 1 levels in patients with operable breast cancer were significantly higher compared with healthy individuals (median 15293 and 3983 pg/ml p < 0.0001). TGF-beta 1 level in plasma of patients with a positive sentinel lymph node was significantly higher than in patients with negative sentinel lymph nodes (high vs low, median 18,9 and 14,5 ng/ml, respectively, p = 0.05). CONCLUSION The determination of TGF-beta 1 status might help to identify a high-risk population early in tumor progression, for which a more appropriate therapy should be established. In the node-negative population, the up-regulation of TGF-beta 1 might constitute an early event that promotes further progression of breast tumors.
Collapse
MESH Headings
- Adult
- Aged
- Biomarkers, Tumor/blood
- Breast Neoplasms/blood
- Breast Neoplasms/pathology
- Breast Neoplasms/surgery
- Carcinoma, Ductal, Breast/blood
- Carcinoma, Ductal, Breast/pathology
- Carcinoma, Ductal, Breast/surgery
- Carcinoma, Lobular/blood
- Carcinoma, Lobular/pathology
- Carcinoma, Lobular/surgery
- Female
- Humans
- Middle Aged
- Risk Factors
- Sentinel Lymph Node Biopsy
- Transforming Growth Factor beta1/blood
Collapse
Affiliation(s)
- J Chod
- Department of Obstetrics and Gynecology, 2" Medical Faculty, Charles University, Prague, Czechslovakia.
| | | | | | | | | | | |
Collapse
|
45
|
Robová H, Rob L, Pluta M, Kacírek J, Slavík V, Skapa P, Hamsíková E, Tachezy R. [Progression and regression low grade intraepitelial squamous lesions in context of positivity of high risk human papillomavirus]. Ceska Gynekol 2007; 72:347-350. [PMID: 18175519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
OBJECTIVE Evaluation of regression and progression of histologically confirmed low grade squamous intraepithelial lesions (LG SIL) in women under the age of 35 in context of positivity of high risk human papillomavirus (HPV HR). Evaluation of sensitivity of PAP smear and HPV HR test in women with LG SIL. DESIGN Prospective study. SETTING Department of Obstetrics and Gynecology, Charles University Prague, 2nd Medical Faculty, University Hospital Motol. PATIENTS AND METHODS 166 women with SIL low or repeated ASC-US PAP smear were included to the study. 1 to 3 punch biopsy under the expert colposcopy and HPV HR test were performed in all women. Follow up were done every 6 month in all women with histologically confirmed LG SIL. RESULTS LG SIL was detected in 120 women. Sensitivity of PAP smear was 72.3% and sensitivity of HPV HR test 60.2 % in women with LG SIL. 84 women (70 %) were HPV HR positive. Regression of LG SIL was detected in 20 (23 %) HPV HR positive women and in 18 (50%) HPV HR negative women. This difference is statistically significant (p = 0.0094). Progression of LG SIL was detected in 24 (29 %) HPV HR positive women and in 4 (11%) women HPV HR negative women. This difference is borderline statistically significant (p = 0.058). Progression of LG SIL to the carcinoma in situ or invasive cancer had not been detected during follow up period. CONCLUSION PAP smear is a standard for LG SIL detection in women under the age of 35 and HPV HR test is not so important for LG SIL detection in this group of women. HPV HR test could be useful for prediction of the risk of progression, but positivity of HPV HR in LG SIL cannot indicate surgical treatment (conisation) in this cohort of women under the age of 35.
Collapse
Affiliation(s)
- H Robová
- Gynekologicko porodnická klinika 2, LF UK a FN Motol, Praha
| | | | | | | | | | | | | | | |
Collapse
|
46
|
Halaska M, Strnad P, Chod J, Malá I, Nováková M, Stankusová H, Kolarík D, Feldmár P, Rob L. [Detection of postoperative lymphoedema in patients with breast cancer]. Ceska Gynekol 2007; 72:299-304. [PMID: 17966613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
OBJECTIVE Lymphoedema is a severe postoperative complication after treatment of many malignancies. It is a pathological accumulation of extracellular water (ECW). Early diagnostic tool is needed. Multifrequency bioimpedance analysis (MFBIA) is a method for detection of changes in ECW. TYPE OF STUDY Prospective study. SETTING Dept. of Obstetrics and Gynaecology of the 2nd Medical Faculty, Charles University, Prague. METHODS We measured a control group of 72 women and a group of 74 patients undergoing a breast cancer surgery during 18 month after the surgery by MFBIA and circumferency. Characteristics of the patients were recorded. The detection of lymphoedema was done using MFBIA, circumferency measurement and upon the symptoms of the patients. RESULTS The average age in the controll and tested group was 40,1 and 58,9 years. The average size of the tumour, grade and positivity if oestrogen receptors was 15,1 mm, 2,04 and 43%. In 23 patients (21%) complete lymphadenectomy was performed, in 51 patients (79%) a detection of sentinel lymph node was performed. Lymphoedema was detected in 8 women (11%). In these patients MFBIA detected lymphoedema 9 month earlier in total than other methods. CONCLUSION MFBIA is a low-cost and precise method for the detection od early stage postoperative lymphoedema. We recommend to incorporate MFBIA into standard dispensatory plan of every patient combined with circumferency measurement.
Collapse
Affiliation(s)
- M Halaska
- Gynekologicko-porodnická klinika 2. LF UK a FN Motol, Praha.
| | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Abstract
Pure endodermal sinus tumor (EST) of the ovary is an uncommon germ cell tumor characterized by rapid growth. Its occurrence during pregnancy is extremely rare. The case of a 34-year-old woman with EST stage IC diagnosed in the 22nd week of gestation is presented. She received four cycles of cisplatin monotherapy during pregnancy. Further, three cycles of combination chemotherapy (cisplatin, bleomycin, and etoposide) were administered. Twenty-eight months posttreatment the patient was in complete remission with good health. A healthy female infant was delivered by cesarean section in the 35th week of pregnancy. The child showed normal laboratory, pediatric, and neurologic examination at the time of discharge from hospital and during the first and second years of her life. We conclude that the prognosis of EST is very good if patient receives adjuvant therapy. Cisplatin monotherapy seems to be effective and safe during pregnancy.
Collapse
Affiliation(s)
- H Robova
- Department of Obstetrics and Gynecology, Faculty Hospital Motol, 2nd Medical Faculty, Charles University Prague, Prague, Czech Republic.
| | | | | | | | | |
Collapse
|
48
|
Halaska M, Rob L, Strnad P, Stankusová H, Komár M, Suchová K, Chod J, Hrehorcák M, Vlk R. [A set of patients with breast cancer associated with pregnancy]. Ceska Gynekol 2007; 72:203-6. [PMID: 17616075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
OBJECTIVE The aim of our study is to follow patients diagnosed with breast cancer associated with pregnancy. DESIGN Prospective follow-up study. SETTING Department of Obstetrics and Gynecology of the 2nd Medical Faculty of the Charles University and Faculty Hospital Motol, Prague. METHODS Between the year 2002 and 2006 12 women were reffered to our department, seven with the diagnosis of breast cancer during pregnancy, three within one year after the delivery, two pregnant after the therapy for breast cancer. A managment was sellected individually with respect to the age of pregnancy, the stage of the disease and to the decision of the women. The average age of the diagnosis, managment, way of delivery, fetal and maternal outcome were recorded. RESULTS The average age was 31.7 years. Two patients underwent a termination of the pregnancy, other delivered a healthy newborn. Two of our patients are dead, three have a metastatic disease, one was lost for follow-up, the rest are further followed. CONCLUSIONS Breast cancer diagnosed during pregnancy is a special and rare situation, which needs to be managed individually as there is a lack of information about such patients. These patients should be concentrated in specialized centers.
Collapse
Affiliation(s)
- M Halaska
- Gynekologicko-porodnická klinika 2. LF UK a FN Motol, Praha.
| | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Chod J, Závadová E, Halaska M, Strnad P, Rob L, Fucíková T. [Transforming growth factor-beta 1 as a marker in patients with operable breast cancer]. Ceska Gynekol 2007; 72:112-5. [PMID: 17639732] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
UNLABELLED OBJECTIVE AND DESIGN OF STUDY: Determination of TGF-beta 1 levels in plasma of patients with operable breast cancer. The correlation of TGF levels with the stage of disease and other prognostic markers. Prospective study. METHODS There were 36 patients fulfilling the entrance criteria included in the study. The blood samples were taken to set the plasma levels of TGF-beta before the operation, with no adjuvant therapy. 27 age matched healthy volunteers served as controls. The study was approved by ethical board and patients signed informed consent regarding blood sampling and results presentation. Differences between groups were determined using the Mann-Whitney U-test. RESULTS We proved that TGF-beta 1 levels are elevated in patients with operable breast cancer. Moreover, TGF-beta in plasma of patients with positive sentinel lymph node was significantly higher as compared to patients with negative sentinel node. Most important is the fact that patients involved in our study were in very early stages of disease. CONCLUSION TGF-beta 1 is marker correlating with breast cancer disease risk factors, especially with positive sentinel lymph node. We conclude that TGF is one of the early markers which may help define the risk of disease progression already before the operation.
Collapse
Affiliation(s)
- J Chod
- Gynekologicko-porodnická klinika 2. LF UK, Praha.
| | | | | | | | | | | |
Collapse
|
50
|
Abstract
Langerhans cell histiocytosis (LCH) affecting child vulva alone is a very rare disease. Only 13 cases of primary vulvar LCH have been previously reported in the medical literature. We describe an additional case in which the LCH was confined to the vulva, with review of the literature. A 16.5-year-old girl presented with papulous and ulcerative lesions on her labia majora and minora. The biopsy revealed a typical histopathologic finding consistent with LCH. A metastatic work-up did not reveal any evidence of the disease except on the vulva. Treatment was carried out according to LCH II protocol. The patient was diagnosed with a recurrent disorder in the vulva 8 months after the completion of primary chemotherapy. For this reason, she underwent second line treatment with 2-chlorodeoxyadenosine. Eighteen months after the second line chemotherapy, the patient has no signs of a local or systemic recurrence. Primary LCH of vulva is very unusual, but we have to keep in mind this possibility when an adolescent girl presents with an atypical chronic lesion on the vulva. This patient appears to be the first case of adolescent 16.5 year old having a solely cutaneous lesion of the vulva
Collapse
Affiliation(s)
- H Mottl
- Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University, Motol, Prague, Czech Republic.
| | | | | | | | | |
Collapse
|